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 ABSTRACT 
 
For many centuries, the osteoblast is considered to be responsible for bone 
formation. It is also believed that an imbalance of osteoblasts (weak) and osteoclasts 
(strong) is the main cause for bone diseases such as osteomalacia and osteoporosis and 
periodontal diseases, globally the most prevalent dental disease. Most studies are aimed 
at these two surface cells, although neither of them penetrates into the deep bone matrix. 
Osteocytes, terminally differentiated osteoblasts, are buried deep in the bone and account 
for up to 95% of all bone cells.  Due to the high mineral density around osteocytes,  most 
people consider them “quiescent” cells. Only recent research revealed more profound and 
important roles of osteocytes, such as mechano-sensors. 
In this study, we developed the innovative  “FITC-Imaris technique”, which 
combines FITC (Fluorescein isothiocyanate), confocal microscopy and Imaris software. 
With this method, we could visualize the 3-D morphology of embedded osteocytesand 
statistically quantitate the osteocyte structure cell surface total cell volume, and dendrite 
numbers. We examined Dmp1 (dentin matrix protein 1) mutant mice, an established 
osteomalacia animal model, and showed both significant morphological and statistical 
differences in the osteocyte structure between the Dmp1-null mice and their age-matched 
control littermates, suggesting a high correlation between osteocytes and osteomalacia. 
Then, we studied periostin knockout mice, a periodontal disease mouse model, and 
found that osteocyte’ morphological and pathological changes are closely linked to 
alveolar bone loss. Monoclonal anti-SOST antibody) restores not only bone loss, but also 
osteocyte morphology, suggesting osteocytes may be responsible for bone loss in periostin 
mutant mice. 
Lastly, we examined OVX rats as an osteoporosis model and showed that Ocys 
failed to maintain their shape, dendrite number and size in response to estrogen deficiency. 
Abnormalities in blood vessel morphology and bone matrices also developed,  resulting 
in osteoporotic changes in both compact and trabecular bone. Similarly,  administering 
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 SOST antibody normalized osteocyte morphology and recovered bone loss  from 
osteoporosis.  
Altogether, we demonstrated that Ocy maturation was directly linked to a slow 
mineralization process. Minerals were constantly “pumped” via Ocy-dendrites to the 
surrounding matrix and to the bone surface. These study results expanded our 
understanding of how osteocytes regulate bone development and mineralization. These 
findings have clinical relevance, as SOST antibody improved bone phenotypes in all 
osteomalacia, periodontal disease and osteoporosis animal models, holding great potential 
for treating human bone disease. 
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 NOMENCLATURE 
AB Alveolar bone 
ALP Alkaline phosphatase 
APC                            Adenomatous polyposis coli 
BSP Bone sialoprotein 
BSEM Backscattered scanning electron microscopy 
BrdU 5-Bromo-2’-deoxyuridine 
µCT Microcomputed tomography 
Ca Calcium 
CEJ                             Cementum-Enamel Junction 
CK1                            Casein Kinase 1 
CKO Conditional knockout 
Con Control group 
Dapi                            4',6-diamidino-2-phenylindole 
DMP1 Dentin matrix protein 1 
DKK1 Dickkopf-related protein 1 
DKO                           Double knockout 
DSPP Dentin sialophosphoprotein 
Dsh (DVL)                  Dishevelled                              
ECM Extracellular matrix 
ER Endoplasmic reticulum  
FITC                           [2, 5]- Fluorescein isothiocyanate 
FGF23 Fibroblast growth factor-23 
FZD                            Frizzled 
GSK                            Glycogen synthase kinase 
Het Heterozygous  
HE Hematoxylin & Eosin  
Hyp loss-of-function mutation of Phex  
IHC                             Immunohistochemistry 
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 IP3                              Inositol 1,4,5-trisphosphate 
KO                              Knockout 
LacZ β-Galactosidase 
LRP5/6 Low-density lipoprotein receptor-related protein 5/6 
MEPE Matrix extracellular phosphoglycoprotein 
MAPK Mitogen-activated protein kinase 
NIH                             National Institutes of Health 
Ob Osteoblast 
OCN Osteocalcin 
Ocy Osteocyte 
OPG                            Osteoprotegerin 
OPN Osteopontin 
OPPG                          Osteoporosis-pseudoglioma syndrome 
OSX Osteorix  
OVX                            Ovariectomized  
PCP                             Planar cell polarity 
PDL Periodontal ligament 
Phex                            Phosphate-regulating neutral endopeptidase, X-linked 
Pi Phosphorus  
PIP2                            Phosphatidylinositol 4,5-bisphosphate 
PKO                            Periostin knockout 
PTH Parathyroid hormone  
Rankl                          Receptor activator of nuclear factor kappa-B ligand 
Runx2 Runt-related transcription factor 2 
SEM Scanning electron microscope 
SOST Sclerostin 
SE Standard error of the mean  
WT Wild type 
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 CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Specific Aims 
 
An imbalance of osteoblast and osteoclast activity attributes may be the main 
reason for the cause of periodontal disease, osteomalacia and osteoporosis, as it has long 
been assumed that osteoblasts build mineral and play a central role in recruiting 
osteoclasts. Recently, Tomoki Nakashima et al.(60) discovered that osteocytes are actually 
the main cells responsible for RANKL production and osteoclast recruitment. As the 
major cell type (more than 90% of cells in mature bone) (6,66), osteocytes also have a 
much longer life span (up to 20 years; some researchers even claim certain osteocytes 
remain alive the entire individual’s life) than any other cell types. It is hard to be convinced 
that osteocytes remain quiescent the whole period. Moreover, osteocytes are found in the 
perfect place (totally buried in the mineral) to sense mineral changes; they are well 
connected with each other and with blood vessels through the canaliculi system. 
To dissect osteocytes’ direct role in bone mineralization and their pathological 
involvement, we used Dmp1 null mice, periostin null mice, OVX rats and osteoporosis 
patient cadavers in our osteomalacia, periodontal disease and osteoporosis study. 
Interestingly, we found that osteocytes have great morphological changes in all disease 
types, together with mineral loss around osteocyte lacunae. Applying an antibody against 
SOST (inhibitory gene of bone formation, mainly expressed in mature osteocytes) 
successfully recovers osteocytes and lost bone mass. Surprisingly, SOST antibody also 
induces blood vessel formation in animal models. Osteoblasts are responsible for collagen 
production as an abundant ER and Golgi complex in the cytoplasm; however, the way 
mineral is transported and laid down still remains unknown. By double labeling and DAPI 
staining (a novel technique developed in this lab), we visualized a great amount of new 
mineral along blood vessels, osteocyte lacuna, osteocyte dendritic processes and the 
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 mineral front. Unexpectedly, a huge gap was present between osteoblast lining cells and 
the mineral front (also confirmed by backscatter imaging on the bone surface), which may 
indicate that osteoblasts do not directly participate in mineral deposition. Dmp1 (21,28) is 
mainly expressed in osteocytes (22,34,82). Dmp1 KO mice (88,89) and Dmp1 human 
mutations (20,25,47,48) cause striking defects in bone (51,91). Primary mouse calvarial 
cell (osteoblasts) culture from Dmp1-lacZ knock-in mice also confirm that mineralized 
nodules only form around lacZ positive cells (mainly fully developed osteocytes) rather 
than undifferentiated osteoblasts. Based on both in vivo and in vitro data, we propose that 
osteocytes are the main cells responsible for mineral transportation, deposition and 
maintaining bone homeostasis; thus, osteocytes could be a potential target for treating 
bone diseases such as osteomalacia, periodontitis or osteoporosis. To address our 
hypothesis, three specific aims are proposed: 
 
Specific Aim 1: To investigate osteocyte changes (cell surface, cell volume and 
dendritic numbers) both qualitively and quantitively by introducing a novel technique 
combining FITC staining, confocal microscope and Imaris quantification software in 
Dmp1 null mice, using an osteomalacia animal model. The osteocyte-canaliculi system in 
the bone is stained by FITC and the 3-dimensional structure is captured by confocal 
microscopy. Finally, osteocyte changes are quantitively analyzed by Imaris (a software 
initially developed for neuron cell studies). We hypothesized that there would be a sharp 
reduction of surface area and dendrite numbers in Dmp1 null mice compared with age- 
matched control groups. Successful development of this technique will provide a great 
tool to study deep embedded cells like osteocytes and help us understand osteocytes’ role 
in bone diseases like periodontal disease and osteoporosis (Aim 2 and Aim 3). 
Specific Aim 2: To determine the role of the PDL (periodontal ligament) and 
osteocytes in periodontal disease and bone development. Periostin null mice were utilized 
as our periodontal disease model, and histological and biochemical studies were done to 
analyze the PDL’s role in alveolar bone formation and the origin of periodontal disease in 
this particular mouse model. Meantime, anti-SOST monoclonal antibodies were 
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 administrated and studied for their potential as a periodontal disease treatment. We 
hypothesize that the PDL is the major cell reservoir for postnatal alveolar bone formation; 
Scl-Ab treatment successfully reverses both alveolar bone defects and loss of PDL 
integrity in periostin null mice; osteocyte changes in periostin null mice are highly 
correlated with periodontal disease. 
Specific Aim 3: To define the essential role of osteocytes in building and 
maintaining mineralized bone. Our hypothesis is that bone mineralization is a long 
process, in which the osteocyte plays a key role in orchestrating the mineral within an 
organic matrix; and that the osteoblast reciprocally supports osteocyte function in 
mineralization. To test this hypothesis, we will 1) use mandibular and femur bone from 
newborn to 5 months to map the maturation of the mineralization matrix and its close 
relationship with osteocyte maturation with both biological and physicochemical 
approaches; 2) both qualitively and quantitively analyze osteocyte change (cell surface, 
cell volume, dendrite numbers) in OVX rat, monkey animal models and osteoporosis 
patients; 3) using osteocyte-less (Dmp1 DTR) Tg mice to specifically delete osteocytes to 
determine if blocking mineral transportation through osteocytes alone has an effect on 
bone mineralization.  
Together these aims will be a major paradigm shift over the understanding of bone 
mineralization from osteoblast-oriented to osteocyte-oriented bone modeling. Elucidating 
the relationship of osteocytes and bone development provide new perspective in treating 
and understanding various bone diseases such as osteomalacia, periodontal disease and 
osteoporosis. Furthermore, successful rescue of bone defects by Scl-Ab administration in 
all three disease types will provide evidence for new drug discovery and patient treatment. 
 
Literature Review 
 
Canonical and Non-canonical Wnt Signaling Pathways 
Wnt is a group of secreted, highly-conserved glycosylated proteins that are often 
found to have lipid modifications (palmitoylation of cysteines) necessary for secretion and 
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 signal transduction. Wnt, first identified as int1 in early mouse oncogenetic studies, was 
then known as Wingless (Wg) in Drosophilia, a segment polarity gene involved in body 
axis development in a morphogenetic manner. By now, Wnt signaling has been well 
studied in various areas - from embryo development to tissue regeneration. In this short 
discussion, we will focus on the role of Wnt signaling in bone development. 
Wnt signaling is classified mainly into two categories: the canonical signaling 
pathway (Wnt-β catenin pathway) and the non-canonical pathway (including the Wnt-PCP 
and Wnt-Ca2+ pathways). Although the Wnt planar cell polarity (PCP) pathway is 
believed to cascade along small G-protein Rho and down-streaming Rac or to modify actin 
polymerization and regulate cell polarization through an alternative rac1-JNK way, its role 
in bone development is not known. The Wnt-Calcium pathway activates phospholipases 
C through Dsh, then the plasma component PIP2 can be cleaved to IP3 through the 
function of activated phospholipases C. IP3 subsequently regulates the calcium release 
from the endoplasmic reticulum (ER). The released calcium is responsible for cell 
migration and adhesion, and it is also suggested to have functions in ventral patterning. 
Recent research has indicated that the Wnt non-canonical pathway, especially the Wnt-
calcium pathway, may be integrated with the β-catenin-initiated canonical pathway 
through Wnt 5a. 
The Wnt β-catenin canonical pathway is initiated by various Wnt proteins; the 
well-studied ones include Wnt3a, Wnt5a, Wnt10b and Wnt 14. In the absence of Wnt 
signaling, β-catenin is sequestered in a complex including tumor suppressor Axin, 
adenomatous polyposis (APC), glycogen synthase kinase (GSK) 3β and casein kinase 1 
(CK1). Β-catenin subsequently will be phosphorylated and targeted for 
polyubiquitination, polyubiquitinated β-catenin will be transported to proteasomes and 
then degraded in this complex. When the Wnt β-catenin pathway is turned off, 
downstream T-cell factor/lymphoid enhancer factor (TCF/LEF) will remain repressed by 
Groucho. Once Wnt is present, it will form a receptor complex with Wnt co-receptor low-
density lipoprotein receptor-related proteins 5 and 6 (Lrp 5/6) and a seven-transmembrane 
receptor FZD (Frizzleds). This complex will recruit Axin through interaction with 
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 disheveled (DVL), which will free β-catenin from the destruction complex. Accumulating 
evidence has shown that a certain amount of β-catenin will still be phosphorylated but 
cannot be polyubiquitinated, resulting in excessive β-catenin that can be subsequently 
translocated into the nucleus. Nuclearized β-catenin will replace TCF/LEF repressor 
groucho and initiate downstream gene expression. 
 
Wnt Signaling (SOST) and Bone Formation 
 
Wnt signaling pathway has been extensively studied for its role in bone formation, 
and it is generally believed to be positively correlated with bone growth. The relationship 
of Wnt signaling with bone came to people’s attention over a decade ago with discoveries 
that mutations in Wnt signaling in 4 different groups of patients resulted in severely altered 
bone strength and density, of which three of the groups saw a dramatically increased bone 
formation while the other one had an osteopenia phenotype. Remarkably, two of the 
mutations occurred in Lrp5, low density lipoprotein receptor-related protein 5, which 
proved to be an important co-receptor for the Wnt-β catenin signaling pathway. A loss of 
function mutation in Lrp5 led to osteoporosis-pseudoglioma syndrome (OPPG), 
resembling a low bone mass phenotype; on the other hand, a gain of function mutation of 
Lrp5 resulted in high bone mass. The other two groups of patients had mutations affecting 
the expression of SOST, or sclerostin, an antagonist of Wnt signaling that usually binds to 
Lrp4, 5 and 6 to prevent Wnt’s association with the receptors. These two groups of patients 
were later known as sclerosteosis and Van Buchem disease, all leading to a high bone 
mass phenotype. Ever since the association of the Wnt canonical pathway and bone 
formation was illuminated, multiple transgenic mouse models were created to explore and 
exploit the possible role of Wnt signaling in bone development.  
One group of well-studied transgenic animal models was related to the SOST gene. 
Sclerostin, the protein product of the SOST gene, is highly expressed by osteocytes and 
long and is hypothesized to be an essential molecule secreted at the bone surface by 
osteocyte, to regulate osteoblast activities. Overexpression of sclerostin led to low bone 
5 
 
 mass as reported by Kramer et al., 2010. Deletion of SOST in mice is fully fertile and 
showed an increase bone formation, bone strength and density by increasing osteoblast 
numbers. Lrp 5 deficient mice are the animal model of OPPG syndrome, showing 
decreased bone density and an osteoporosis-like phenotype. Interestingly, deletion of 
SOST in Lrp 5 null mice fully reversed skeletal fragility, and the treatment of Lrp5 null 
mice with neutralizing sclerostin antibody rescued reduced bone mass and bone density. 
In fact, SOST is one of the few Wnt pathway genes selectively expressed in bone tissue, 
which makes it a promising target for drug design to treat bone-related diseases such as 
osteoporosis.  
Dkk1 (Dickkopf-related protein 1), like sclerostin, binds with Lrp receptors to 
inhibit Wnt signaling. Dkk1 is highly expressed in osteoblasts, conventional knockout of 
Dkk1 lead to embryo death since DKK1 is an important molecule for head induction; 
however, Dkk1+/- heterozygote mice showed increased bone mass. Overexpression of 
Dkk1 led to osteopenia in the long bone, retarded mandibular tooth formation and 
demineralized calvaria. Dkk1 neutralizing antibody has been developed and showed 
increased bone formation at the endosteal side in an ovariectomy-induced osteopenia 
mouse model. Unlike SOST, Dkk1 expression is not limited to bone, so a systematic 
attribution of Dkk1 antibody may result in unwanted effects. 
β-catenin is believed to be the essential molecule that determines mesenchymal 
cell fate and couples bone formation with bone resorption. The conditional knockout of β-
catenin at an early osteoblast stage by using Osx-cre developed cranial ossification defects 
and increased chondrogenesis. The late osteoblast stage oblation of β-catenin by 2.3 col1-
cre resulted in both increased osteoblasts and osteoclasts; however, the Opg/RankL ratio 
was significantly lower, which led to reduced bone mass. The osteocyte stage oblation of 
β-catenin by Dmp1-cre also produced impaired bone quality and decreased bone 
formation with decreased Opg expression and more active osteoclasts. Current research 
proved that exon 3 of β-catenin encodes for a region consisting of several serine and 
threonine sites for phosphorylation by Gsk3β, which will direct β-catenin to be 
polyubiquitinated and degraded. Multiple clinical cases revealed that the deletion of exon 
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 3 in β-catenin is the cause for tumor genesis by stabilizing β-catenin in the cytoplasm. 
Numerous exon 3 conditional deletion mice were developed to study the role of 
constitutive activation of β-catenin (CA- β-catenin) in bone development. Osx-cre induced 
CA- β catenin resulted in early embryo death and premature ossification with increased 
proliferation of pre-osteoblasts. Interestingly, cranial ossification in this cKO mice was 
delayed while the overall skeleton showed early mineralization. This may due to the fact 
that β-catenin has different functions in modulating intramembranous bone formation 
versus endochondral bone formation. 2.3 Col1-cre induced CA- β-catenin led to postnatal 
lethality and osteopetrosis with decreased osteoclast numbers. Osteocyte stabilization of 
β-catenin by Dmp1-cre produces phenotypes similar to those of 2.3 Col1-cre: 1) Delay of 
teeth eruption due to a decreased number of osteoclasts; 2) stunted mandibular tooth root 
formation; 3) immature osteocytes (OSX staining positive) with a flattened and cuboid 
cell body and reduction of dendritic processes; and 4) trabecularization of cortical bone. 
In conclusion, the β-catenin-mediated Wnt canonical pathway is a pivotal 
signaling pathway for bone formation, which is tightly controlled and interplays with 
multiple other signaling pathways such as Bmp, IHH and FGF signaling. Inhibited Wnt 
signaling in bone led to osteoporosis or osteopenia while increased Wnt signaling may 
lead to osteopetrosis and premature bone formation. Meantime, although being very 
promising, the idea of utilizing Wnt signaling-based drugs, for instance, the anti-sclerostin 
neutralizing antibody and anti-Wnt small molecule inhibitors, must be closely modulated 
to evaluate not only the effectiveness but also side-effects.  In addition, Wnt β-catenin 
signaling may have different functions in different origins and types of bone development 
(intramembranous bone formation vs. endochondral bone formation). Further research 
will need to be done to illustrate how Wnt signaling is fine tuned to achieve balanced bone 
formation during development. 
 
Summary 
Osteocytes make up over 90-95% of bone cells (6,66). Evidence is accumulating 
that osteocytes are more active than previously thought (13,15); they regulate osteoclast 
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 formation in bone (60,87) and play a key role in the mechanical strain reaction and 
coordination of adaptive bone remodeling responses (6). However, there are major gaps 
in our knowledge of osteocyte function during mineralization because: a) it is extremely 
difficult to study these cells, as they are buried in the mineralized matrix; b) currently no 
clear pathways have been identified that are in charge of the maturation from osteoblasts 
to osteocytes; and c) few diseases and animal models are linked to osteocyte functions. In 
this study, we first developed a new FITC-confocal-Imaris analysis technique that enables 
both qualitative and quantitative analysis of osteocytes, we also identified the Wnt 
canonical pathway to be responsible for the maturation of osteoblasts (an increased 
amount of Wnt-β-catenin is the key causative factor in the development of osteomalacia, 
which blocks the transformation of Ob into Ocy), and thus maintains overall healthy bone 
homeostasis. Last we utilized three different animal models (Dmp1 null mice as 
osteomalacia disease model, Periostin null mice as the periodontal disease model, and 
OVX rat as an osteoporosis model) to study the role of osteocytes in bone disease 
development. The inhibition of SOST function by Scl-Ab injection (activation of Wnt β-
catenin signaling) restores bone loss and improved bone quality in all three animal models, 
which provides insights into new targets for drug development to treat patients with bone 
disease. 
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 CHAPTER II 
A NOVEL WAY TO STATISTICALLY ANALYZE MORPHOLOGIC CHANGES IN 
DMP1-NULL OSTEOCYTES* 
Synopsis 
 
Recent studies have revealed multiple roles of osteocytes in bone metabolism. 
However, detailed analyses of the embedded osteocytes in bone structure are still limited 
because of the high mineral content around these cells. In this study, we developed an 
innovative technique, the “FITC-Imaris technique”, which combines FITC ([2, 5]- 
Fluorescein isothiocyanate), confocal microscopy and Imaris software. With this method, 
we could not only visualize the 3-D morphology of embedded osteocytes, but more 
importantly, we were able to statistically quantitate the osteocyte structure in the cell 
surface, total cell volume, and dendrite numbers. Furthermore, we made a side-by-side 
comparison of the new method with the acid-etched SEM imaging technique, a common 
imaging method for studies of osteocyte morphology with a much smaller cell depth (< 3 
µm). Finally, we used the FITC-Imaris technique to show both the morphological and 
statistical differences in the osteocyte structure between the Dmp1-null mice (the 
osteomalacia model) and their age-matched control littermates.  We expect that this newly 
developed technique will become a powerful tool to disclose more roles that osteocytes 
play in bone health and diseases(71). 
 
Introduction  
Osteocytes account for more than 90% of the total number of cells in mineralized 
bone. However, most bone studies have focused on the surface cells, such as osteoblasts 
*Reprinted with permission from “A novel way to statistically analyze morphologic 
changes in Dmp1-null osteocytes” by Y Ren, S.Lin, Y. Jing, et al, 2014. Connective Tissue 
Research PVol.55 Suppl 1pp:129-133, Copyright [2014] by Informa Healthcare.  
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 and osteoclasts, partly because these cells are more active in metabolism and are 
technically easier to access. However, recent studies have revealed more profound and 
important roles of osteocytes in addition to their role as mechanosensors. These roles 
include regulation of bone formation by secreting sclerostin proteins (5,32),  bone 
resorption through the production of a great amount of RankL(60), control of phosphate 
homeostasis through FGF23 (25), and regulation of primary lymphoid organs and fat 
metabolism. Therefore, analyzing osteocytes in a more efficient and precise way is vital 
and necessary in bone biology studies. 
One of the traditional methods of evaluating mineral-embedded bone cells is 
known as “acid-etched SEM” (25). Resin is packed into the non-mineralized structures 
during sample embedding; after acid treatment, the mineral is removed to expose the 
underlying resin-filled structures.  Although a high-resolution, acid-etched SEM image 
can reveal the osteocyte-canalicular system, this technique has several limitations: 1) The 
optimal acid concentration and treatment time vary among samples, depending on the 
sample hardness and structure (thus, the process is time consuming). Oftentimes when the 
condition is optimized for mineralization defect samples like Dmp1-null bones, the 
mineral cannot be fully removed from the control samples under the same conditions; 2) 
The SEM technique can only be applied efficiently when the sample surfaces are polished 
so that all scratches are eliminated, although polishing removes many dendrites protruding 
from the osteocytes; and 3) Only the top layer of the osteocyte is uncovered, while cell 
processes deeply embedded in mineral remain hidden. Thus, a true 3-D analysis technique 
for osteocytes needs to be developed to enhance the understanding of the detailed 
osteocyte structure. 
FITC is a small fluorescent molecule that penetrates all non-mineralized tissues. 
In bone studies, this molecule fills in the entire prospective osteocyte-canalicular system, 
surrounding blood vessels and osteoid layers, as well as surface cells such as osteoblasts 
and osteoclasts. However, there is a lack of good quantitative methods for defining the 
cell surface, volume, dendrite number, and average length of the dendrite.  
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 Dentin matrix protein 1 (DMP1) has been shown to be a key factor in osteocyte 
biology and bone development. Functional studies have revealed that DMP1 is essential 
for the maturation and function of osteocytes via both local and systemic mechanisms 
(22,25,89). Genetic research identified that DMP1 mutations in humans or its deletion in 
mice lead to autosomal recessive hypophosphatemic rickets, characterized by severe 
osteomalacia bone changes with significant reductions in bone mineralization (22). 
Although the osteocytes of Dmp1-null mice have been characterized by SEM, 
immunohistochemical staining and other methods, the morphologic changes in them still 
have not been quantified and analytically documented.  
In this study, we developed an innovative technique, which we call the “FITC-
Imaris technique”, because it combines FITC, confocal microscopy and Imaris software 
to statistically quantitate the osteocyte structure in the cell surface, total cell volume, and 
dendrite numbers. Our results revealed for the first time the statistical analysis of the 
detailed cell structures in healthy and Dmp1-null osteocytes. We predict that this study 
will have great impact on future studies of osteocyte roles in bone diseases such as 
osteoporosis.  
 
Experimental Procedure 
 
Mouse, rat and human specimens 
 
Eight-week-old Dmp1 null mice and Dmp1 heterozygote littermates were 
analyzed in this study. After they were sacrificed, the right side of the tibia was removed 
for testing and evaluation.  In addition, the technique is further demonstrated through the 
use of human and rat bone. All animal protocols were approved by the Animal Welfare 
Committee at Texas A&M University Baylor College of Dentistry. 
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 FITC sample preparation and staining for confocal imaging 
 
The muscle was removed from the mouse tibia, and the tibia bone was rinsed in 
PBS, followed by fixation in 70% ethanol for two days at room temperature with a one-
time change of 70% ethanol. The bone samples were slowly dehydrated in 95% ethanol 
for one day and 100% ethanol for one day. The samples were stained with 1% FITC 
(Sigma, cat. no. F7250) in 100% ethanol overnight, followed by continuous dehydration 
with 100% ethanol for one more day and acetone for 2 days; they also underwent the 
plastic embedding process described previously (19).  Notably, during the FITC staining 
process, additional dehydration, and the plastic embedding process, the bones were kept 
away from light by wrapping them in aluminum foil. The human specimen obtained from 
femur cortical bone and the rat tibia were cut to cubic size by a diamond saw for 
dehydration, which followed the same procedure as described above. 
The embedded plastic blocks were sectioned using a water-cooled diamond-
impregnated circular saw (Isomet, Buehler) into approximately 1-2-mm-thick slices. 
These slices were further sanded down to < 100 µm thickness using six grades (80, 200, 
400, 600, 800, and 1200 grit) of sanding papers, and polished on a soft cloth rotating wheel 
with 1-µm alumina alpha micropolish II solutions (Buehler, no. 406323016). After 
polishing, the slides were immersed in a water-soluble mounting medium for confocal 
imaging and then covered with a plastic coverslip.  
 
Confocal microscope imaging 
 
The SP5 Leica confocal microscope located at Baylor College of Dentistry was 
used to gather Z-stack images. The FITC samples were subjected to 488-nm wave length 
excitation using an argon laser and emission at 520 nm. All the images were captured at 
light ranging from 500 to 540-µm wavelengths. Multiple stacked images were taken at 
200 Hz and 1024x1024 dimensions using 63X glycerol objective lense at 1.5 times 
magnification. For both the Dmp1 HET and the null mice, a thickness of 32 µm was 
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 obtained with a pixel size of 0.1542 µm x 0.1542 µm x 0.49 µm from the tibia cortical 
bone midshaft area. The ideal cubic pixel size was revised from 0.1542 x 0.1542 x 0.1542 
µm to 0.1542 x 0.1542 x 0.49 µm in order to reduce possible fluorescence bleaching from 
prolonged exposure of tissues to laser light. For the human and rat specimens, a thickness 
of 35 µm was obtained for imaging using the same parameters. 
 
Image J, Autoquant and Imaris analyses 
 
To obtain good optical image quality, the stacked confocal images stored as Tiff 
files were converted to a multilayer Tiff file using Image J software. The images were 
uploaded to Autoquant software for deconvolution. The dimensions for the pictures 
entered into Autoquant were set at 0.1542 x 0.1542 x 0.49 µm.  Blind 3-D deconvolution 
was performed after selecting the magnification and the optical medium for confocal 
imaging.  The Autoquant output file was then imported into Imaris for filament tracing 
and statistical quantification. The same threshold parameters were set for the osteocyte 
body (7.85 µm for the filament tracing start point) as well as the dendrite length (0.485 
µm for the end point) for both the Dmp1 heterozygote (HET) and Dmp1-null specimens.  
The computed cell bodies were then manually corrected according to the FITC confocal 
images. After tracing, the filament surface area, volume, length, and terminal point 
number were all collected and selected for statistical analyses. 
 
Data analyses 
 
Osteocytes (20-25) from the middle of the tibia cortical bone region were chosen 
to be quantitatively analyzed. Statistical significance was determined by an independent-
sample t-test using SPSS 12.0. A p value of < 0.05 was considered statistically significant. 
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 Results 
 
Comparison between the acid-etched SEM and FITC imaging techniques 
 
To better understand the advantage of the FITC-confocal imaging technique, we 
did a side-by-side comparison of both images. As shown in Fig 1-1 a, the maximum 
thickness of the osteocyte-lacuna image on the bone surface was less than 3 µm, which 
equals approximately half the thickness of the osteocyte. Therefore, this image could not 
be used for quantification.  In contrast, an approximately 30-µm thickness of the stacked 
image could be obtained using the FITC-confocal technique with no distortion of the 
osteocyte structure using one photon laser beam (Fig 1-1 b, which is a diagram showing 
the difference of the imaging area covered by both techniques). Fig 1-1 c gives an example 
of the rat tibia cortical bone (approximately 5 µm thick; note that only the middle 10 slices 
of the series picture from the confocal microscope are stacked, to give a better view of the 
cell structure), in which the osteoblast lining cells, osteoclasts, and osteocytes are well 
documented in the same frame. Fig 1-1 d illustrates an osteon (the basic bone unit in 
mammalian compact bone) from a 30-year-old human male femur; the detailed structure, 
approximately 35 μm thick, includes the Haversian canal; many osteocytes, plus a large 
amount of dendrites, are visible. 
 
Dmp1 null mice showed a significant increase in osteoid accumulation associated with 
a sharp reduction in dendrites and cell volume in osteocyte structure. 
 
Imaris is Bitplane’s scientific software that was originally developed for neuronal 
visualization and interpretation of 3D microscopy datasets. We have adapted this software 
for analyzing osteocyte FITC images qualitatively and quantitatively. As an example, we 
took separate FITC images of the HET and Dmp1-null compact bones (Fig. 1-2 a, step 1). 
Next, the osteocyte and its dendrites were traced using this software (Fig. 1-2 b, step 2), 
and the original images were then removed (Fig. 1-2 c, step 3). Finally, the data were 
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 processed for statistical comparison (Fig. 1-2 d, step 4), which showed significant 
reductions in cellular surface, total volume, and dendrite length and numbers, supporting 
the notion that DMP1 is essential for osteocyte maturation in the structure  
 
 
 
Discussion  
In the present study, we developed a novel technique combining FITC confocal 
imaging and Imaris software, which not only enables the visualization of the true 3-D 
morphology of non-decalcified compact bone cells, but also statistically analyzes the 
morphologic differences among the healthy and the Dmp1-null osteocytes. This technique 
shares many similarities with the acid-etched SEM imaging technique, such as sample 
preparation and visualization of the 3-D osteocyte structure. The technique offers the 
following advantages: 1) much broader bone areas can be evaluated, including cells on the 
bone surface (osteoblasts and osteoclasts) and the interior structures, including both 
osteocytes and the osteon structure;  2) no extra physical and chemical treatments are 
required; thus, a natural cell distribution with essentially no tissue distortions can be seen; 
and 3) most importantly, the buried osteocytes and their dendrites can be precisely 
analyzed both qualitatively and quantitatively. 
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 CHAPTER III 
VITAL ROLES OF OSTEOCYTES IN RESTORATION OF BONE AND PDL 
DEFECTS IN PERIODONTITIS* 
Synopsis 
 
The development of an effective treatment for bone loss and PDL (periodontal 
ligaments) damage in periodontitis has been a longstanding aim in dentistry and medicine. 
Osteocytes account for over 90% of bone cells, although their relationship with the PDL 
and periodontitis is largely unknown. In this study, we initially documented a 2- and 3-
fold faster rate in the PDL than in the periosteum and endosteum, respectively. Further, 
we demonstrated the origin of alveolar bone cells from PDL progenitor cells using the 
Cre-loxP technique. We then identified ectopic ossification in the PDL and pathological 
changes in osteocyte morphologies from spindle to round with sharp reductions in 
dendrites in a severe periodontitis patient. A similar osteocyte change plus increases in 
SOST (Wnt inhibitor) occurred in periostin-null mice. Subsequently, we showed that 
removing Sost or blocking SOST by the SOST antibody rescued the bone phenotype and 
made improvements in the PDL morphologies and expressions of biglycan and decorin in 
periostin-null mice. We propose that (1) PDL functions as the key reservoir for alveolar 
bone formation; (2) The osteocyte defect is responsible for bone loss in periodontitis; and 
(3) blocking SOST function restores bone loss is in part through enhancing PDL 
progenitor cells. 
 
Introduction 
The periodontal ligament (PDL), positioned between the bone forming the socket 
wall and the cementum covering the tooth root, was named in part because of rich of fibers 
*Part of this chapter is reprinted with permission from “Removal of SOST or blocking its 
product sclerostin rescues defect in the periodontitis mouse model” by Y Ren, X Han, SP 
HO, et al, 2015. FASEB J, pii: fj.14-265496, Copyright [2015] by The FASEB Journal. 
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 in this unique structure. These fibers connect the tooth to the jaw bone, support the tooth 
in the socket, and buffer loads imposed on the tooth, thus protecting the tooth and adapting 
to tooth movement and occlusal function. Because PDL contains osteogenic progenitor 
cells, it is widely believed that these cells, like bone marrow cells, contribute to alveolar 
bone formation before molecular biology era. However, there is a lack of in depth in vivo 
studies on the basic role of PDL in alveolar bone formation.  
Periodontitis, the most common disorder known to mankind, is defined as a set of 
complex diseases that include different types of gingivitis and periodontitis. The real 
causes of these diseases are still largely unknown, as they could be of developmental, 
inflammatory, traumatic, neoplastic, genetic, or metabolic origin, although pathogenic 
microflora in the biofilm or dental plaque are the common causes. Gingivitis, the mildest 
form of periodontal disease, affects 50–90% of adults worldwide. Inflammation that 
extends deep into the tissues and causes loss of supporting connective tissue and alveolar 
bone is known as periodontitis (67). The advanced form results in loss of connective tissue 
and bone and accounts for 10-15% of adults in population studies (17,29,30) who suffer 
from tooth loss. Moderate periodontitis is estimated to affect even more people (68). 
Furthermore, there are  afew pieces of evidence that supporta two-way relationship 
between periodontitis and diabetes (i.e., diabetes increases the risk for periodontitis, and 
periodontitis negatively disturbs glycemic control (9,35,39,57,68,78). Because the early 
or moderate condition is typically asymptomatic, many patients are unaware till the 
disease progresses to affect the teeth. Development of an effective treatment for bone loss 
in these diseases has been a longstanding aim (67).  
Sclerostin, a potent inhibitor of Wnt signaling, is highly expressed in an osteocyte 
(Ocy). The sclerostin antibody (Scl-Ab) has been shown to have great efficacy in the 
treatment of a number of pre-clinical models for osteoporosis and bone fracture healing 
(1,38,42). Recent studies showed that this monoclonal antibody can be used to prevent 
bone loss in a model of inflammation-induced bone loss (18), and in an experimental 
periodontitis rat model (81). However, it is not known how and why blocking Scl works 
in inflammation-induced bone loss.  
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 Genetic animal models are widely used not only to prove causes and consequences 
of genes and disease relationships, but also to test the potential of drug therapeutics. For 
example, Periostin is highly expressed in PDL cells during adult life as demonstrated by 
in situ hybridization and immunohistochemistry (74,75,85), and Periostin-knockout (KO) 
mice have been used for studies of periodontal diseases (73,75,76), as this animal model 
recaptures many characteristics of human periodontal diseases, including early onset of 
periodontal bone loss, PDL inflammation and pocket formation. In contrast, Sost-KO mice 
have a dramatic increase in bone mass with no apparent abnormality in morphology (45). 
In this study, we sought to investigate the biological significance of PDL in normal 
alveolar bone formation and the possible impact on chronic periodontitis with a focus on 
the intervention of the Sost gene or its function in periostin KO mice at the cellular and 
molecular levels. Our findings support the novel concept that the PDL plays a far more 
important physiological role than that of the periosteum and the endosteum in alveolar 
bone formation. We also found a surprising pathological change (from spindle to round 
with a sharp reduction in dendrites) in the osteocyte (the cell accounting for over 90% of 
bone cells) in the periostin KO mandible. Translational studies have showed that the 
deletion of Sost or treatment with Scl-Ab fully prevented or reversed bone loss in periostin 
KO mice, likely through reversing osteocyte structure and function. Furthermore, these 
interventional approaches greatly improved the PDL structure, which raised new hope for 
the future treatment of patients with periodontitis, as there is currently no surgical or drug 
method that can be used to restore the PDL structure.  
 
Materials and Methods  
 
Mice, dog and human tissue 
    Periostin, sclerostin double knockout mice were created by mating periostin and 
sclerostin null mice. Ten-month-old dog mandibles were generously offered by Dr. Peter 
Bushang in the Orthodontic department at Baylor College of Dentistry. Human tooth and 
mandible bone specimens were provided by Dr. Zhengguo Cao from Wuhan University 
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 in China. All animal protocols were approved by the Animal Welfare Committee at Texas 
A&M Health Science Center Baylor College of Dentistry. 
 
 
Scl-Ab injection into periostin null mice 
 
To evaluate the function of anti-sclerostin monoclonal antibody in periodontal 
disease treatment, WT and periostin null mice were both injected with 25 mg/kg Scl-Ab 
twice a week for 8 weeks; control mice were injected with saline as placebos in both WT 
and periostin null mice. Injection started at 4 weeks and 12 weeks of age; after injection, 
the mice were sacrificed at 12 weeks and 20 weeks of age, respectively.  
 
Adeno-virus injection into Rosa-26 mice   
 
One-month-old Rosa-26 mice were subjected to adeno-virus injection. The virus 
was injected in the periodontal ligament around both molars and incisor using a 0.2 mm 
fine needle. Samples were collected at 5 days and 10 days post-injection for lacZ staining 
to trace the migration and development of the PDL cells. 
 
Double fluorochrome labeling  
 
To analyze the difference in the bone formation rate in the periosteum, endosteum 
and PDL in the mandible, double fluorescence labeling was performed as described 
previously (50,58). Briefly, calcein (5 mg/kg i.p.; Fluka) was administered 7 days before 
sacrifice, and alizarin red (20mg/kg i.p; Sigma) was injected for the 2nd labeling at 2 days 
before sacrifice. The mandibles were removed and fixed in 70% ethanol for 48 h. The 
specimens were dehydrated through a graded series of ethanol (70–100%) and embedded 
in methyl-methacrylate (MMA, Buehler, Lake Bluff, IL) without decalcification. Fifty-
µm sections were cut using a Leitz 1600 saw microtome. Then the plastic sections were 
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 viewed under a Leica-Sp5 confocal microscope. The mean distance between the two 
fluorescent labels was determined and divided by the number of days between labels to 
calculate the deposition rate of bone from different origins (periosteum vs. endosteum vs. 
PDL)(70). 
 
Histology 
 
The teeth (mice, dog and human) were all fixed in freshly prepared 4% 
paraformaldehyde in phosphate-buffered saline (pH 7.4), decalcified, and embedded in 
paraffin using standard histological procedures as previously described (22). The tissue 
blocks were cut into 4-µm thick mesio-distal serial sections to compare the tissue samples 
from the experimental and control groups and were then mounted on glass slides. The 
sections were used for H&E staining, trap staining, Sirius red staining and 
immunohistochemistry (Dmp1: 1:400, provided by Dr. Chunlin Qin from Baylor; Mepe: 
1:400; Biglycan and Decorin: 1:1000, provided by Dr. Larry Fisher from NIH; Periostin: 
1:1000, Innovative Research; OSX: 1:400, abcam; SOST: 1:400, R&D). 
 
Backscattered scanning electron microscopy (SEM) and resin-casted SEM  
 
The mandibles were dissected and fixed in 70% ethanol at room temperature for 
24 h. The tissue specimens were dehydrated in ascending concentrations of ethanol (from 
70% to 100%), embedded in MMA without decalcification and sectioned through the 
center of the first mandibular molar using a water-cooled diamond-impregnated circular 
saw (Isomet, Buehler). The cut surface was polished using 1, 0.3 and 0.05 μm alumina 
alpha micropolish II solutions (Buehler) on a soft cloth rotating wheel (58). Each sample 
was placed in an ultrasonic bath between steps and immediately following the polishing 
steps. The dehydrated specimens were then sputter-coated with carbon and scanned with 
a backscattered electron detector in a JEOL JSM-6300 scanning electron microscope 
(JEOL, Japan). The parameters were kept constant while the backscattered SEM images 
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 were taken. Next, the carbon-coated samples were repolished, as described above. The 
surfaces were acid-etched with 37% phosphoric acid for 2-10 seconds, followed by 5% 
sodium hypochlorite for 20 minutes. The samples were then sputter-coated with gold and 
palladium, as described previously (25,54), and examined in the scanning electron 
microscope.  
 
FITC staining and Imaris Analysis 
 
FITC staining (10)- Fluorescein isothiocyanate, a small molecular dye, fills in the 
PDL cells/fibers as well as the cementoblast and cementocyte cells but does not enter the 
mineral matrix. Thus, the dye provides a visual representation of the organization of the 
PDL and osteocytes under the confocal microscope. After harvesting and dissection, the 
jaw bones were stained by FITC (Sigma, cat. no. F7250)  overnight during the dehydration 
and embedding process at room temperature and then processed to obtain cortical sections 
and cancellous bone blocks. Cross section (300-400 μm thick) were cut with a diamond-
bladed saw (Buehler, Lake Bluff, IL), and the plastic sections were then sanded and ground 
to a final thickness of 30-50 μm for confocal imaging. Stacked pictures were processed to 
Autoquant (Mediacybernetics, Rockville, MD) for deconvolution and subsequently to 
Imaris (Bitplane, Switzerland) to quantify the cell surface area, volume and dendrite 
ending points of the osteocytes as previously described by Ren et.al.  
 
Micro-CT and CEJ-Bone level area quantification 
 
The mandibles from 4 different groups in both age sets (12 weeks old and 20 weeks 
old when sacrificed) were dissected from the mice and analyzed by x-ray radiography 
(piXarray 100, Micro Photonics) and a μ-CT35 imaging system (Scanco Medical, 
Basserdorf, Switzerland). The μ-CT analyses included: 1) a medium-resolution scan (7.0 
μm slice increment) of the whole mandible from the mice for an overall assessment of the 
shape and structure; 2) a high-resolution scan (3.5 μm slice increment) of the alveolar bone 
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 (teeth were set upright during scan, 400 slices were chosen starting from the alveolar bone 
level) for analysis of the alveolar bone around the 1st molar. The data acquired from the 
high-resolution scans were used for quantitative analyses. Bone volume to total volume 
ratio (BV/TV) was obtained and analyzed using the Scanco software. The data are reported 
as mean ± S.E. 
To quantify the area within CEJ (Cementum-Enamel junction) and bone level 
before and after treatment in all groups, 4 mandibles in each of the 4 groups (named the 
WT group, WT + Ab group, Periostin KO group, Periostin KO + Ab group) both 12-
weeks- and 20-weeks-old were scanned by micro-CT (Scanco-35, Switzerland) in high 
resolution to quantitate periodontal bone loss. Similar to previous reports by De souza (79) 
and Kuhr(41), the lost bone area was restricted by the alveolar bone crest (ABC), the 
cementum-enamel junction (CEJ), the mesial root of the 1st molar and the distal root of 
the 3rd molar. The 3-D mandible images were firstly virtually sectioned to expose both 
root canals of the 3 molars in order to align the mandible perpendicularly, and then the 3D 
images were restored for quantification. Lost bone area was contoured and calculated by 
Image J (NIH, USA).  
 
Statistical analysis  
 
Statistical significance was determined by One-Way ANOVA followed by 
Bonferroni post hoc comparisons between two groups using SPSS 13.0.  A P value of < 
0.05 was considered statistically significant. 
 
Results 
 
Patients with periodontitis display ectopic bone formation and severe inflammation in 
the PDL 
Bone loss and inflammation are key characteristics of patients with periodontitis, 
which is routinely diagnosed by an oral pocket formation using X-ray and local 
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 examinations with no biopsy required. To explore actual pathological changes in this 
disease, we initially analyzed the extracted teeth, in which the PDL and alveolar bone 
tissues were attached, from the two cases of patients with severe periodontitis. As 
expected, both alveolar bone samples displayed chronic inflammation with large amounts 
of plasma cells, a few lymphocytes, and TRAP (tartrate-resistant acid phosphatase) 
positive cells, as well as bone loss (Fig. 2-S1 a). Unexpectedly, in the first case the 
radiograph and H&E images revealed ectopic ossifications in the PDL regions adjacent to 
the acellular cementum layer (Fig. 2-S1 b). The enlarged H&E image documented Ocy-
like cells in the ectopic bone region (Fig 2-1 a). These bone-like cells expressed low levels 
of DMP1 (Fig 2-1 b, the gene highly expressed in Ocy) and MEPE (Fig 2-1 c, the gene 
expressed in Ob and Ocy) with an extremely low level of perisotin (Fig 2-1d, the gene that 
is essential for the integrity of PDL (74,75)). The FITC (Fluorescein isothiocyanate)-
confocal images (8) showed fibers only in the patient PDL (Fig 2-1 e), dramatic changes 
in Ocy cell shape (from spindle to expanded round), and cell distribution (a loss of osteon, 
the basic bone formation unit) in the alveolar bone (Fig 2-1 f-g). The above data indicate 
that human PDL progenitor cells may directly contribute to the ectopic bone formation, 
and that the loss of PDL progenitor cells and pathological changes of osteocytes can 
explain in part the failure for the compensation of bone loss in the periodontitis patient. 
 
The PDL progenitor cells are the key for alveolar bone formation 
 
Although it was speculated that the PDL could form alveolar bone long before the 
molecular biology era, there is no in vivo experimental evidence supporting this 
assumption. To test this hypothesis we initially compared the bone formation rate on the 
PDL-alveolar bone surface, periosteum bone surface, and endosteum surface using pre-
labeled fluorochrome specimens (Calcein injection first, and Alizarin Red injection 
second 5 days apart) from one-month-old mouse jaw bones. The double labelling confocal 
image demonstrated a statistically significant difference among these regions with the 
fastest deposition rate on the PDL-alveolar bone surface, which is 2- and 3-fold faster rate 
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 in the PDL than in the periosteum and endosteum, respectively (Fig. 2-2 a, P < 0.05). In 
the enlarged view, a double labeling layer was observed around an OCY, indicating a 
direct mineral contribution from the OCY cell (Fig. 2-2 b). Further, we observed a small 
amount of minerals (yellow color, overlaid with green and red color) in the PDL area 
adjacent to the bone surface, supporting the mineralization started from the PDL adjacent 
to the alveolar surface. A similar indication that OCYs come from the PDL progenitor 
cells was confirmed by the FITC-confocal technique (Fig 2-2 c). In addition, we used the 
acid-etched SEM technique, a sensitive method for revealing trace amounts of minerals in 
bone matrices (29), and the close relationship between the mineral sheet and the osteocyte-
canalicular system, indicating contributions of osteocytes in mineralization (Fig. 2-2 d). 
For the definite confirmation of the progenitor resource of alveolar bone cells from the 
PDL progenitor cells, a local injection of adenovirus CMV-CRE into the PDL and 
periosteum (as a positive control) regions of the Rosa26 jaw bone were carried out and 
followed by X-gal stains of these samples 5 days after injection. The blue cells in the 
mandible cortical bone and alveolar bone regions indicated their origins were from the 
periosteum (Fig 2-2 d, left) and the PDL (Fig 2-2 d, right) respectively. Taken together, 
the above data support the notion that alveolar bone is formed from three different 
progenitor cell pools: PDL, periosteum and endosteum; and that the PDL progenitor cells 
play a far more important role in alveolar bone formation. 
  
Removing the Sost gene or treatment with Scl-ab fully prevented or greatly improved 
bone loss in periostin KO mice  
 
Previously, we showed that periostin KO mice develop a periodontitis-like 
phenotype due to the loss of the PDL integrity (74,75). Here we re-examined this KO 
mouse line and found an unpredicted change of Ocys from spindle-to-round shape in the 
jaw bone (Fig. 2-S2 a-b) but with no apparent changes in the periostin KO long bone (Fig. 
2-S2 c). Moreover, there was a sharp increase in SOST expression in the periostin KO jaw 
bone (Fig. 2-S2 d) with no apparent change in SOST in the KO tibia (Fig. 2-S2 e). These 
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 data support the notion that the local changes in Ocy in morphology and SOST expression 
is partly responsible for the periostin KO bone loss.  
Because deletion of Sost led to a great increase of bone volume in long bone (45), 
we studied the Sost KO jawbone phenotype and showed a similar bone volume increase 
in alveolar bone plus the development of the osteon, the basic bone unit that occurs only 
in mammals but not in rodents (Fig. 2-S3). Then, we reasoned that removing Sost in 
periostin KO mice could rescue the Ocy and bone-loss phenotype. To test this hypothesis 
we first generated double KO (DKO) mice and showed the full prevention of the bone 
phenotype by radiography (Fig 2-3 a) and µCT techniques qualitatively and quantitatively 
(Fig 2-3 b-c). We also demonstrated the prevention of the following pathological changes 
in the bone matrix and Ocy morphology in the DKO mice: i) poor bone mineral matrices 
in the jaw bone as reflected by a mixed appearance of grey (low mineral) and white (high 
mineral) color with a lack of white rings surrounding the Ocy cell bodies; ii) the Ocy shape 
change from spindle to round; and iii) a full prevention of both bone matrices and cell 
shapes in the DKO bone using backscattered SEM (Fig 2-3 d) and acid etching SEM (Fig 
2-3 e) approaches.  
We next asked whether treatment of periostin KO mice with Scl-Ab, a clinical trial 
drug that is used for treatment of osteoporosis (55,65), can prevent or rescue the bone loss 
in this mouse model. To achieve this goal, the animals were i.p. injected with Scl-Ab 
starting from the age of one month when animals display no apparent phenotype (for 
prevention purposes) or three months when the animals had already developed the 
periodontitis-like phenotype (74,75) (for treatment purposes) for 8 weeks, separately. In 
the prevention group, the radiographic images (Fig. 2-S4 a) and µCT images (Fig. 2-S4 b) 
showed no apparent changes in alveolar bone volume compared to the control group. The 
quantitative uCT analysis confirmed a full prevention of bone loss in the early-treated KO 
group (Fig. 2-S4 c). 
To address whether the prevention of bone loss was directly linked to the Ocy 
morphological change, we developed a novel approach combining FITC images with 
IMARIS software (which was originally developed for neuronal visualization and 
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 quantitation of 3D datasets) to quantify the Oyc-laculo-canalicular system in vivo (Ren et 
al. in press). In these non-decalcified mandibles, we randomly examined the FITC images 
from a WT, a non-treated and a treated group at age of 3 months, and traced 20 Ocys and 
their dendrites qualitative and quantitative comparisons. In the non-treated periostin KO 
samples there were significant reductions in Ocy volume, length and number of dendrites 
(Fig 2-4). These pathological changes were fully prevented in the Scl-ab treated cortical 
bone, supporting the notion that the direct role of Scl-ab on Ocy morphology is the key to 
prevention of bone loss in this animal model. 
In further support of the above hypothesis, we took the same approaches and 
compared the effectiveness of the Scl-ab on the treatment of bone loss in the 3-month-old 
periostin KO group. Both the radiographic image (Fig 2-5 a) and µCT data (Fig 2-5 b) 
showed a great rescue of alveolar bone loss. The cementum-enamel junction (CEJ) to bone 
level area reflected by µCT images, a new method developed for estimating the degree of 
alveolar bone loss, revealed a significant amount of alveolar bone loss in the periostin KO 
mice and great improvement in the Scl-Ab treated group (Fig 2-5 c). The backscattered 
SEM images (Fig 2-5 d) and acid-etched SEM images revealed a severe bone volume 
reduction in the entire alveoli and a great loss in minerals surrounding the Oyc-laculo-
canalicular system in the periostin KO alveolar bone (mid), which was fully restored in 
the Scl-Ab-treated jaw bone (right), supporting a close correlation between the changes of 
Ocy morphologies and matrix mineral contents, and the key role of Ocys in the 
developmental bone loss and treatment in this periodontitis animal model.  
 
Removing the Sost gene or blocking SOST function restored cellular and molecular 
readouts in the periostin KO alveolar bone and PDL  
 
To define the impact of removing the Sost gene or blocking SOST function on 
cellular and molecular changes in the periostin KO alveolar bone and PDL, we did a series 
of histological and immunohistochemical analyses. In the periostin KO mice, both bone 
resorption (as reflected by TRAP expression in Fig 2-6 a, middle) and formation (a 
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 compensated reaction, as revealed by levels of osterix (59), Fig 2-6 b, middle) were high, 
although the bone quality was poor, reflecting a low level of DMP1 (Fig 2-6 c, middle). 
Further, in the periostin KO PDL, the expression of biglycan (Fig 2-6 d), decorin (Fig 2-
6 e), and collagen (as reflected by polarized light, Fig 2-6 f, middle) were greatly reduced. 
All these pathological changes were fully reversed when Sost was removed (Fig 2-6, right 
images, double KO). Similarly, 8-week-treatment of periostin KO with Scl-ab achieved 
the same rescue effect (Fig. 2-S5, right images), supporting the notions that Scl-ab not 
only restores the bone phenotype but also greatly improve PDL phenotype in the periostin 
KO mice. 
 
 
Discussion 
 
Control of chronic periodontal disease, the most common human disease, has been 
the focus of intense investigation for many decades because of the destruction of the PDL 
and the loss of bone and teeth in these patients. In this study, we took a totally different 
strategy and focused on osteocytes in both the patient bone sample and animal studies, 
instead of concentrating on changes of cytokine and inflammation processes as commonly 
performed. For example, we first identified extensive ectopic bone-like tissues in the 
patient PDL region adjacent to the acellular cementum (Fig. 2-1 and Fig. 2-S1 b). This 
finding agrees with the in vitro studies that human PDL cells express bone markers and 
form mineral-nodules (2,44). Next, we demonstrated enormous pathological changes in 
the PDL and osteocyte, including the loss of PDL cells, a shape change of the osteocytes 
from spindle to round, a huge increase in the cell body but a sharp reduction in the dendrite 
number and length, and a change in the cell distribution from surrounding the Haversian 
canal arrangement in the osteon structure to a totally disorganized cluster pattern (Fig. 2-
1 e-f). In combination with our previous report that the osteocyte played a critical role in 
mineralization (25), we propose that both a loss of PDL progenitor cell and defects in 
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 osteocyte morphologies account for in part a severe bone loss in the patient with severe 
periodontitis.   
To further support the critical role of PDL in the human disease case, we compared 
the PDL’s contribution to alveolar bone formation with other well-established bone 
progenitor resources (periosteum and endosteum) in one month old mice. It is clear that 
the bone formation rate originating from PDL progenitor cells is even faster than the 
periosteum and endosteum. Both the cell lineage assay and FITC imaging data are in 
agreement with the notion that the PDL cells play a far more important role in alveolar 
bone formation than is commonly believed (Fig. 2-2). 
The pathological changes in osteocytes in the periodontitis patient are not 
predictable. To directly link this change to bone loss was initially challenging, since we 
know very little about this cell in bone mineralization. Because there was a sharp reduction 
in the expression of periostin in the patient PDL (Fig. 2-1 d), and the periostin KO mice 
develop many characteristics of the human periodontitis phenotype such as early onset of 
periodontal bone loss, PDL inflammation and pocket formation (73,75,76), we studied 
their osteocyte morphologies using multiple techniques. Again, this animal model 
developed the same osteocyte phenotype as in the human patient (Figs. 2-3-5). Further, 
because of a great increase in SOST in the periostin KO mice (Fig. 2-S2) and the close 
correlation between the optimal change in osteocyte morphologies and the increase in 
alveolar bone volume (Fig. 2-S3), we generated double KO mice. The full prevention of 
osteocyte and bone loss phenotype in these double KO mice not only confirmed our 
hypothesis but also triggered our next step to address whether blocking SOST function 
rescues osteocytes and the  bone phenotype in the periostin KO mice using the monoclonal 
Scl-ab. The data obtained from the prevention group (early treatment before the bone 
phenotype appeared) and the rescue group (the treatment initiated after the bone loss) are 
exciting, as both osteocyte and bone loss phenotypes are prevented or greatly rescued. 
What’s more, the PDL phenotype is greatly improved in the double KO and Scl-ab treated 
mice (Fig. 2-6, and Fig 2-S5). At this stage, we do not know why and how the PDL 
phenotype is reversed by blocking SOST function, as periostin is mainly expressed in PDL 
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 and SOST is highly expressed in alveolar bone. However, based on a close association 
between the Sharpe’s fibers and osteocytes in the alveolar bone regarding their structural 
connection and gene expression patterns (Fig 2-S6), we speculate that there might be an 
interaction among them in this special environment, which is altered during periodontitis, 
leading to local changes in osteocyte morphologies. On the other hand, deletion of Sost or 
blocking SOST function may send a positive signal to PDL progenitor cells for repairing 
damages in both the PDL itself and alveolar bone through Sharpe fibers. In other words, 
the Sharpe fibers not only connect the PDL and alveolar bone but also function as a bridge 
between these two tissues in signaling interaction. 
In summary, in this study we demonstrated that (1) the PDL functions as the most 
important reservoir for alveolar bone formation; (2) Morphological changes in osteocytes 
are responsible for bone loss in both the patient with periodontitis and the periostin KO 
mice; (3) Deletion of Sost or blocking SOST function prevents/restores bone loss via 
reversing osteocyte morphologies; and (4) Restoration of the PDL phenotype by Scl-ab 
treatment in the periostin KO mice shed a new light on future drug development, as there 
is no success in repairing PDL damage in patients with chronic periodontitis. 
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 CHAPTER IV 
THE OSTEOCYTE IS THE KEY TO BONE MINERALIZATION 
 
Synopsis  
 
The theory that osteoblasts (Obs) form bone is the cornerstone of bone biology, 
although the role of the osteocyte (Ocy), the most abundant bone cell with a half-life of 
decades, remains speculative despite its ideal location to initiate and maintain 
mineralization.  Using comprehensive imaging techniques, we demonstrated that Ocys, 
whose maturation is directly linked to a slow mineralization process, constantly “pump” 
minerals via their dendrites not only to the surrounding matrix, but to the bone surface as 
well.  Next, we showed that mineralization defects occurred when Obs failed to form Ocys 
in Dmp1-null mice with osteomalacia.  Mechanism studies of Dmp1-null mice revealed a 
surprising increase in β-catenin in bone, which is responsible for abnormal mineralization. 
On the other hand, when Ocys failed to maintain their shape, dendrite number and size in 
response to estrogen-deficiency, abnormalities in blood vessel morphology and bone 
matrices developed, resulting in osteoporotic changes in both compact and trabecular 
bone.  These findings demonstrate that Ocys are the key cells in bone mineralization, and 
defective Ocy maturation and function may underlie abnormal mineralization in 
osteomalacic diseases (Supplementary Fig. 3-1)  
 
Introduction 
 
 The osteocyte, defined as the terminally differentiated cells derived from 
osteoblasts located within the bone matrix, comprises more than 90% to 95% of all bone 
cells in the adult skeleton. Previously, osteocytogenesis was considered a passive process, 
during which osteoblasts produced a matrix/osteoid and became trapped under new 
osteoid over the embedded cells (31,61). However, in the last decade, there was a virtual 
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explosion of data on the molecular biology and function of osteocytes. Far from being the 
“passive placeholder in bone”, this cell type has demonstrated numerous functions, such 
as remodeling the bone (3), producing hormones such as the parathyroid hormone 
(4,72,77) and estrogen (40,86), acting as a mechanosensory cell (80), regulating bone 
resorption via osteoclasts (63,87), and working as an endocrine cell via connections with 
the vascular system (14). More clinical observations indicated that osteocytes were 
important for bone mineralization and maintenance. For example, the functional disorder 
of osteocytes leads to osteoporosis, a disease affecting 55% of Americans aged 50 or above 
and is responsible for millions of fractures annually (53,62,90). The differentiation of 
osteoblasts into osteocytes occurs in several stages, including osteoid osteocyte (or newly 
formed osteocyte), mineralized osteocyte, and mature osteocyte (7). Therefore, the 
osteocyte was one of the key cells involved in skeleton development and homeostasis, and 
the identification of the mechanisms underlying its differentiation and maturation process 
helped to further the understanding of bone biology in order to develop skeletal disease 
therapy. 
Subjects and Methods 
Animals 
All animal studies were performed in accordance with the guidelines of the Baylor 
College of Dentistry, TX A&M Health Science Center, and Amgen IACUS review board. 
Thehuman cadavers used were from the BCD anatomy teaching lab and exempted from 
the IRB of Baylor College of Dentistry. C57BL/6 Dmp1-null mice (24) and Hyp mice, 
which were purchased from Jackson Labs, were used in this study (6 weeks old, 4 in each 
group, no blinding or randomization is performed during sampling). Previous examination 
of these mice showed no apparent differences between sexes, between heterozygous (Het) 
and wild-type (WT) mice in any parameters measured to date, representative data were 
shown in this paper. The 12-year-old cynomolgus monkey humorous bone samples 48 
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months after OVX or sham treatment were generously provided by Dr. Cynthia J. Lees 
(Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, 
NC, USA) from previous studies(43). Rat OVX and sham bone samples with and without 
8-week Scl-ab treatment were from previous studies (46,64). The rabbit dye injection (5% 
sodium metaperiodate with a molecular weight at 214, Fisher Scientific) was carried out 
through the abdominal aorta catheter approximately onminute apart from the dye injection 
and fixation. The midshaft of the femur was decalcified and used for TEM analysis as 
described previously (25). 
Preparation and analyses of bone samples: 
              Procedures for bone sample preparation and high resolution X-ray, uCT, TEM, 
FITC-Confocal, and SEM were described previously (25). For TEM images the thin 
sections were cut and stained with uranyl acetate and lead citrate and examined using a 
Philips CM12 in STEM mode. For resin-casted osteocyte-lacuno-canalicular SEM, the 
surface of methylmethacrylate embedded bone was polished followed by acid etching with 
37% phosphoric acid for 2-10 seconds, 5% sodium hypochlorite for 5 minutes, then coated 
with gold and palladium, and examined by FEI/Philips XL30 Field emission 
environmental SEM (Hillsboro, OR). Standard methods for H&E, Goldner’s Masson 
Trichrome staining, polarized light microscopy imaging, immunohistochemistry, and in 
situ hybridization using digoxigenin-labeled cRNA probes have been described 
previously(91). To analyze the role of osteocytes in mineralization, mice were injected 5 
days apart with calcein (5 mg/kg i.p, 1st), and alizarin red (20 mg/kg i.p, 2nd), and dogs 
were injected 10 days apart with the same reagents and dosages plus one more time of 
calcein injection (i.e., 3-time-injections). The animals were sacrificed 2 days after the final 
injection. The 10 µm non-decalcified samples from these animals were photographed 
using a Leica TCS SP5-II upright microscope for fluorochrome labeling combined with 
and without DAPI staining of nuclei of osteocytes.  
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Visualization of the osteocyte-canalicular system by Fluorescein isothiocyanate 
(FITC), a small molecular dye, will fill in all cells, dendrites and blood vessels (but will 
not enter the mineral matrix) followed by a MMA embedding method previously 
described (8) (Ren et al., in press). Thus, the dye provides a visual representation of the 
organization of the osteocyte-canalicular system and blood vessels under the confocal 
microscope. A cross section with around 1 mm thickness were cut with a diamond blade 
saw (Buehler, Lake Bluff, IL), and the sections were then sand ground to final thickness 
of ~50 μm for confocal images. 
Statistics 
All datasets were independent two tailed normally distributed with equal variances 
(levene's test). Student t-test was carried to compare mean differences between two 
groups, if there were more than 2 groups for comparison, one-way ANOVA was used and 
bonferroni adjustment was applied to measure differences between each one. All were 
performed by using SPSS 13.0 and all data were recorded as mean+s.e.m (standard error 
of the mean), a P value <0.05 was considered statistically significant (*, p <0.05; **, p < 
0.01; ***, p<0.001). 
Results 
            To test the hypothesis that Ocys are essential for bone mineralization, we 
initially used electron microscopic techniques and found a close association between slow 
Ocy maturation and the lengthy mineralization process, reflected by the gradual transition 
of the mineral content from an extremely low level at the osteoid layer through the early 
mineral layer with a poorly organized sphere-like mineral structure   the mature matrix 
layer, in which the Ocys were fully mature and the mineral was continuous 
(Supplementary Fig. 3-S2). We then confirmed the apparent role of Ocys in mineralized 
bone formation using a confocal FITC imaging technique, which showed that the poorly 
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organized, irregularly shaped Ocys with few dendrites were present in trabecular bone 
having relatively low mineral content, whereas well organized spindle-shaped Ocys with 
numerous dendrites were present in cortical bone with relatively high mineral content. 
These observations were further affirmed upon examination of human osteoporotic bone, 
which displayed dramatic changes in the Ocys, from a spindle shape to a round shape with 
few dendrites (Supplementary Fig. 3-S3) , indicating a close association between Ocy 
structures and  status of  mineralization.  
While the mineralization process has been well characterized in vitro, we have 
little information regarding the in vivo mechanisms that regulate mineralization (84).  In 
the present study, we showed that the absence of mineralization in the newborn calvarial 
matrix occurred in association with the presence of nascent Ocys that had few dendrites. 
After 10 days, however, the appearance of plump young–Ocys heralded progressive 
mineralization in the calvarium.  By 3 weeks, the Ocys transformed into a spindle shape 
surrounded by a solid mineral matrix.  At 5 months, fully mature Ocys, reduced to one-
half their original size, exhibited the replacement of depleted cytoplasm by mineral (Fig. 
3-1 a). Similarly, the mineralization of long bones closely correlated with Ocy maturation 
and a gradual reduction of the Ocy volume. The resulting vacant space was filled by 
mineral, leading to bone growth (Fig. 3-1 b).   
To confirm the functional role of Ocys in the mineralization process, we examined 
double-labeled fluorochrome specimens under confocal microscopy, which revealed small 
amounts of mineral surrounding the cells and dendrites.   As shown in Figs. 3-1 c (cortical 
bone), 3-1 d (trabecular bone), Supplementary Figs. 3-S4-S5, there was a double label not 
only at the bone surface, but in the bone matrix surrounding the Ocys as well, although 
there was no fluorescent label surrounding the Obs at the bone surface as predicted. These 
data support the novel concept that Ocys embedded in the bone matrix, not Obs on the 
bone surface, directly contribute to the mineralization of the surrounding matrices and the 
bone surfaces. Thus,  in patients with osteomalacia, the abundant unmineralized osteoid is 
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not related to the Obs at the bone surface (3) but to the embedded Ocys that fail to pump 
mineral to the surface (Supplementary Fig. 3-S1).   
The ability of the Ocy to form mineralized bone is, of course, dependent upon the 
appropriate transfer of oxygen and nutrients from blood circulation.  However, it is widely 
believed that there are few blood vessels in mineralized bone and that the canalicular fluid 
outside the Ocys transports nutrients to the Ocys (7). Interestingly, however, the acid-
etched SEM (Fig. 3-2 a-b) and FITC images (Fig. 3-2 c) showed evidence of high blood 
vessel density, plus numerous connections between the blood vessels and the Ocys. 
Indeed, a single dye injection assay, via a catheter inserted into a rabbit abdominal aorta, 
documented large amounts of dye in the cytoplasm of the Ocy bodies and their dendrites 
in < 2 minutes (Fig. 3-2 d and Supplementary Fig. 3-S6), indicating a rapid exchange and 
delivery of mineral between the capillary and Ocys.  
To understand the molecular mechanisms by which Obs are transformed into Ocys 
and the role of Ocys in bone formation, we studied Dmp1-null mice, an animal model of 
osteomalacia, in which Obs fail to form Ocys (91).  Initially we confirmed that the deletion 
of the Dmp1 gene, which is highly expressed in Ocys (26,82), leads to severe defects in 
Ocy morphology and mineralization (Supplementary Fig. 3-7). Unexpectedly, however, 
we found numerous Ob-like cells buried in the osteoid of the null-bone matrix, with no 
evidence of peri-cellular mineral deposition (Fig. 3-3 a-b).  These Dmp1-lacZ-positive 
cells divide (Fig 3-3 c-d), produce abundant collagen (Fig 3-3 e) and express high levels 
of Ob-markers, such as Runx2, Osx, Cox-2, osteocalcin (OC) and Tcf1.  The Ocys present 
in the bone matrix are irregularly shaped plump cells, consistent with arrested maturation, 
which are surrounded, in part, by poorly mineralized tissue (3-3 f-j).  These data suggest 
that: 1) although producing collagen, Obs apparently do not directly contribute to mineral 
deposition; and 2) the arrested transition of Obs to Ocys and failure of Ocy maturation 
likely result in abnormal mineralization. Furthermore, DMP1 appears to be a key molecule 
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controlling the transition of Obs into Ocys, along with their maturation (Supplementary 
Fig. 3-S1). 
Although the mechanism by which DMP1 effects the above changes is unclear, 
our previous data showed that sclerostin (a potent inhibitor of Wnt-β-catenin), which is 
highly expressed in mature Ocys (83), was sharply reduced in the immature Dmp1-null 
Ocys (Supplementary Fig 3-S8)(91)(51). Consistent with the reduced sclerostin 
expression, we found evidence from immunochemical and x-gal staining of a sharp 
increase in the Wnt-β-catenin levels in the Dmp1 null mouse bone (Figs 3-4 a-b).  
Quantitative bone RT-PCR data showed greater than10-fold increases in β-catenin in the 
Dmp1-null mice compared to the control mice (n = 8, P < 0.01). In addition, the bone 
displayed a high level of TCF1 (Fig. 3-3 j), a key downstream molecule of β-catenin (16).  
To assure that the observations in the Dmp1-null mouse were independent of the  elevation 
of Fgf23 mRNA, we generated and studied the offspring of a cross between Dmp1-Cre 
(49) and Ctnnb1ex3flox (36) mice, in which high levels of β-catenin in the bone were 
confirmed (data not shown).  The osteomalacia phenotype was documented by multiple 
microscopic and staining criteria (Figs 3-4e-k, Supplementary Fig. 3-S8) and low serum 
Pi levels (8.11 mg% compared to 11.61 mg% in control, n=4, P <0.01) with no changes 
in FGF23 levels (171 pg% compared to 195.7 pg% in control, n=4, P =0.7). These findings 
not only demonstrate the vital role of DMP1 in controlling the maturation of Obs into 
Ocys but also identify the key pathological role of Wnt-β-catenin in osteomalacia. 
. 
Discussion 
For over a century, the osteoblast has been viewed as the cell responsible for bone 
formation. Furthermore, it has been widely believed that an imbalance of osteoblast 
(weak) and osteoclast (strong) function is the main cause for osteoporosis, a common 
disease affecting the senior population in particular.  Most, if not all, studies are thus aimed 
at these two bone surface cells, although neither of them can penetrate into the deep bone 
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matrix. In fact, over 90-95% of bone cells are osteocytes, which are derived from 
osteoblasts. Our understanding of the function of these long-lived (for decades) cells is 
extremely limited. One of the most difficult challenges in studying in vivo osteocytes is 
how to quantitatively and qualitatively define the osteocyte changes in healthy, diseased, 
and different unloading conditions. To this end, we have developed a novel approach 
combining FITC images with IMARIS software (which was originally developed for 
neuronal visualization and quantitation of 3D datasets) to study osteocytes and bone 
vessels. In this manuscript, we examined the FITC images from a 30 years old white male 
control and a 98 years old osteoporosis patient bone (all from cadavers), in which the 
osteocytes (which were altered from a spindle to a round shape) had greatly increased in 
the cell bodies but sharply decreased in dendrite numbers. To quantitate the difference, 
the osteocytes and their dendrites were traced using this software, and the original images 
were then removed. Finally, the data were processed for statistical comparison, which 
showed significant reductions in volume, length and number of dendrites but great 
increases in the number of cell bodies with a reduction in the actual contact surface 
between osteocytes and matrices. This sharp pathological change is likely responsible for 
bone loss in the osteoporosis. 
In this manuscript, we also attempted various approaches, including a critical novel 
method (double labeling plus DAPI stain), to demonstrate that osteocytes are the key cells 
in building mineralized bone and maintaining bone homeostasis. We also identified 
Dmp1, to be the critical molecule during the process of osteoblast maturation into 
osteocyte. As deletion of Dmp1 led to osteoblast-like cells instead of mature and well-
differentiated osteocytes. Meantime, increased osteoblast and decreased osteocyte 
activities in Dmp1 null mice led to under-mineralized osteomalacia phenotype, suggesting 
robust osteoblast function alone does not guarantee balanced bone homeostasis.  
           In the search for the molecular mechanism and potential treatment of bone loss in 
osteoporosis, we found a sharp increase in SOST expression in the osteoporosis patient 
bone, likely responsible for bone loss in the osteoporosis. Because a loss of the sclerostin 
gene in mice (SOST KO) or treatment of WT mice with SOST-Ab all result in great 
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increases in bone volume. SOST (sclerostin) is the antagonist for canonical Wnt-β-catenin 
signaling pathway. Administration of anti-SOST monoclonal antibody has successfully 
restored bone loss, as well as altered osteocyte morphology in OVX rat-an osteoporosis 
animal model, which may give people great hints in future anti-osteoporosis drug design 
and test. 
In summary, our studies indicate that Ocys are the key cells for bone 
mineralization. Therefore, defective Ocy function likely underlies osteomalacia and 
possibly other disorders of bone formation, such as osteoporosis. 
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CHAPTER V 
CONCLUSION 
For over the last several decades, bone biologists have widely accepted the idea 
that osteoblasts are responsible for building bone based on its location on the bone 
surfaces. Without doubt, osteoblasts possess abundant rough ER and Golgi complex, 
which contributes to the collagen synthesis and assemble during bone formation. 
Meantime, however, both collagen and mineral are needed to construct a solid bone 
structure, and there is no evidence supporting osteoblasts’ role in mineral secretion or 
transportation. Our prelimary data strongly suggests that, osteocytes play an equal role as 
osteoblasts, if not more important, in bone mineralization during development. Osteocytes 
are well connected with each other and get nutrient supply from blood vessels through 
lacunae-caniliculi system, also by which, mineral is transported from vessel to each 
individual osteocyte and to the bone mineral front (which is supported by our confocal-
double labeling imaging technique, all the lacunae, dendritic processes and mineral front 
are labelled with calcein green and alizarin red, Fig 3-1). Dmp1 is essential for the 
maturation of osteoblast to osteocytes, Dmp1 deletion will lead to similar osteomalacia 
phenotypes with osteoblast-like osteocytes failing to maintain and build mineral, which is 
identified with abundant osteoid formation. Failure to maintain osteocytes’ function in 
Dmp1 null osteomalacia model, Periostin null mice model, OVX rat animal model and 
osteoporosis human specimen all revealed failure to sustain normal bone hemostasis, 
indicating osteocytes play a vital role in bone remodeling. Application of SOST antibody 
not only restores normal osteocyte morphology, as well as normal bone mass, 
mineralization defect and several gene expressions. Close correlation between osteocytes 
function and bone quality underlies a key role for osteocytes in bone diseases progressing 
and its prospective in drug design. 
Sclereostin (SOST) is the ligand for LRP5/6 receptor and antagonist of Wnt-β-
catenin signaling pathway. It has been studied for the possible function of regulating 
osteoblast activity through osteocyte. However, with a higher concentration of SOST and 
39 
10X greater surface area osteocyte has over osteoblast, as well as a better understanding 
of the mineralizing function of osteocytes, we reason that osteocytes are actually the main 
target cell of SOST and SOST works as an endocrine-like factor locally to regulate bone 
mineralization through osteocytes rather than osteoblasts. Successful completion of this 
study enabled us to clarify SOST function on bone formation, proved its new involvement 
in blood vessel development, as well as evaluated anti-SOST monoclonal antibody itself 
as a new clinical treatment to bone/vessel related diseases. 
Dmp1 Mediates The Maturation of Osteoblast to Osteocyte Through Wnt-β-catenin 
Signaling Pathway 
N-linked Glycoprotein (SIBLINGs) family belongs to numerous non-collagenous 
proteins (NCPs), which makes an important component of bone and dentin extracellular 
matrix (ECM). The SIBLINGs family shares similar intron/exon properties, conserved 
protein biochemical properties and specific peptide motifs (e.g., phosphorylation and 
integrin-binding RGD). To date five members in this SIBLINGs family have been 
identified: Dentin matrix protein 1 (DMP1), osteopontin (OPN), bone sialoprotein (BSP), 
matrix extracellular phosphoglycoprotein (MEPE), and dentin sialophosphoprotein 
(DSPP) (27). DMP1 was originally identified by cDNA cloning from the rat dentin matrix 
(33) and was initially believed to be dentin specific but was later proved to be largely 
produced by bone (12,26). Studies suggested that DMP1 initiates its expression at E15.5 
and resides mainly in osteoblasts during embryonic development. However, postnatally 
Dmp1 is mainly expressed by differentiated osteocytes in the bone (22,82). The Dmp1 
gene was mapped at 4q21 (the long (q) arm of chromosome 4 at position 21) in humans 
and at 5q21 in mice. Dmp1 has 6 exons and 80% of its coding information reside in exon 
6. Two promoter control domains for Dmp1 have been identified: a proximal one located
between the -2.4 kb and the +4 kb region, and a distal one between the -2.4 kb and -9.6 kb 
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 region. The proximal domain controls DMP1 expression at early stages, and the distal 
domain controls the later stages (52).  
Mutations of Dmp1 in humans or its deletion in mice have been identified to cause 
a novel disease: autosomal recessive hypophosphatemic rickets (ARHR), which is 
characterized as inadequate or delayed mineralization of osteoid in mature or spongy 
bones; hypophosphatemia (which is mainly due to renal phosphate wasting); and 
ultimately a deficiency or impaired metabolism of Vitamin D, phosphate and calcium. 
Based on the reported cases, the primary clinical symptoms of ARHR show “lower limb 
deformities (bowed legs or knock-knees), waddling gait, short stature or stunted growth, 
tooth abscesses or early loss of teeth, bone and muscle pain, biochemical abnormalities 
(hypophosphatemia with normal levels of serum calcium and parathyroid hormone).  More 
severely afflicted patients may also suffer from nerve deafness, facial and dental 
abnormalities, learning disabilities, joint pain, and contracture and immobilization of the 
spine. Patients diagnosed with ARHR display symptoms in their early childhood that are 
likely to have a wide spectrum of severity, depending on the site and size of the mutations 
and the severity and chronicity of the associated phosphate depletion.”(23).  
Dmp1-null mice do not show obvious abnormalities during embryo bone 
development.  However, the bones are severely impaired postnatally which are 
characterized by short and widened long bones, flared and irregular metaphyses, and 
delayed ossification centers (89). Dmp1-null animals displayed significantly lower serum 
phosphorus levels than the wild type controls when compared with the human cases, which 
is due to increased urinary phosphate excretion accompanied with increased FGF23. 
Furthermore, the levels of 1,25-dihydroxyvitamin D [1,25(OH)2D3] were inappropriately 
normal, whereas the serum PTH level significantly increased in the Dmp1-null mice 
(25,51,91). Bone histological studies demonstrated that the Dmp1-null mice displayed 
severe osteomalacia bone changes with significant defect in bone mineralization. 
Moreover, the Dmp1-null mice showed increased osteoid area and more porous cortical 
bone. Under higher-magnification back-scattered scanning electron microscopic images, 
the minerals, which are evenly distributed around the osteocyte lacunae in normal 
41 
 
 condition, were either absent or sparsely located in regions surrounding the Dmp1-null 
osteocytes. The scanning transmission electron microscopic images indicated a much 
lower content of mineral, calcium, and phosphorus in the Dmp1-null mineralized matrix 
(25,51,91) 
Compared with normally differentiated osteocytes, Dmp1-null osteocytes display 
bulky and coarse microstructural features, as well as abnormally enlarged and round-
shaped osteocytes accompanied by a reduction in dendrite numbers (25,51,91). Dmp1 was 
identified as a key regulator of the differentiation and maturation of osteocytes from 
osteoblasts (69,91). However, how this molecule regulated this process, or which 
signaling pathways control it were largely unknown. In our separate study, we evidenced 
that there is a sharp increase of β-catenin in Dmp1 null mice (Fig 4-1). To prove the 
essential role of Wnt-β-catenin signaling pathway during osteocyte maturation, we crossed 
the Dmp1-Cre mice with β-catex3loxP/loxP mice, which introduced a constitutive stabilization 
of β-catenin in the osteocytes. The off springs recaptured osteomalacia phenotype as 
observed in Dmp1 null mice, as well as altered osteocyte morphology and function (Fig 
4-2). Similarly, normalizing Wnt-β-catenin activity in Dmp1 null mice by crossing Dmp1 
null with DKK1 transgenic mice greatly improved hypophosphatemic 
rickets/osteomalacia phenotype (Fig 4-3). Our pioneer data strongly suggest Dmp1 
regulate bone mineralization and osteocyte maturation likely through Wnt-β-catenin 
signaling pathway. 
 
SOST Mainly Targets Osteocytes for Its Anabolic Effect on Bone 
 
Bones have two unique features: high mineral content and non-stop remodeling 
lifespan. For many decades, the osteoblast has been widely considered as the cell 
responsible for bone formation, while the osteoclast’s function is bone resorption. Based 
on studies in the physiological effects of spaceflight on the body, bone loss is the most 
adverse effect, which takes a long time to reverse. The common belief is that an imbalance 
between osteoblast and osteoclast activity during spaceflight contributes to bone loss with 
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 the mechanism similar to the aging-caused osteoporosis. Although great efforts have been 
made to solve this critical issues, there has been no real breakthrough, partly due to the 
fact that most studies focus only on these two short-lived bone surface cells. 
It is well documented that loading increases bone volume via the reduction of 
SOST in osteocytes, and unloading results in bone loss due to an increase in the Sost 
expression in the osteocytes. It is also known that Sost-knockout mice maintain a much 
larger bone volume compared to control mice in the tail suspended model (62). The current 
belief is that as a mechanosensor, the osteocyte secretes more sclerostin in the paracrine 
manner into bone marrow under mechanical unloading and that SOST reduces Wnt/β-
catenin signaling and inhibits bone formation in the bone marrow, resulting in bone loss. 
SOST, or sclerostin, has been well studied for its potent role as an inhibitor of Wnt-
β-catenin signaling and a negative regulator of bone formation (38). And the Sclerostin 
antibody (Scl-Ab) treatment has been shown to have great efficacy in the treatment of a 
number of pre-clinical animal models and clinical trials of osteoporosis and bone fracture 
healing (11,37,46,56,64). However, how SOST function and what cells SOST target have 
been a myth over decades.  
Although it has been suggested SOST might be targeted on osteoblast and is a 
potential molecule through which the osteocytes can control bone remodeling. However, 
as stated earlier, SOST is not a growth factor, and it doesn’t seems logical for this potent 
inhibitory factor produced in the osteocyte to “travel” to the bone marrow, in which SOST 
inhibits osteogenesis. Our preliminary data have already demonstrated that it is the 
osteocyte and not the osteoblast that forms mineralized bone. Thus, it is important to 
demonstrate that SOST directly regulates osteocyte activity in an autocrine manner in the 
mechanical unloading condition.  
Here we proved that SOST modulate bone metabolism mainly through osteocytes 
in an autocrine manner rather than targeting on osteoblasts (Fig 4-4). By tracing SOST 
LacZ staining in SOST null heterozygote, in-situ hybridization and western blot, we 
confirmed that there is constitutive expression of SOST from osteo-progenitor cells in the 
bone marrow through mature osteocyte with an increased level (Fig 4-5), suggesting that 
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 sclerostin is not secreted from osteocytes to the bone surface but is produced by progenitor 
cells and osteoblasts themselves, and sclerostin production increases over time as 
progenitor cells mature to osteocytes. In vitro study also evidenced that only osteocyte 
responds to anti-sclerostin antibodies but not osteoblast, Scl-Ab greatly reduced SOST 
production in MLOY4 cells, and decreased RankL and increased Dmp1 significantly. But 
there are no apparent changes of these genes expression levels in MC3T3 cell line (Fig 4-
6). We have reasoned that SOST mainly targets on osteocyte to modulate bone 
homeostasis by regulating RankL production.  
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FIGURES 
 
 
Figure 1-1.  Pros and cons of acid-etched SEM and FITC techniques in imaging bone 
cells. (a) Acid-etched, high-resolution SEM image displayed resin-casted osteocyte (Ocy)-
canalicular system on the bone surface; (b) The diagram reveals the difference between 
the SEM and FITC imaging techniques with the former showing mineral-buried Ocy on 
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 the surface only and the latter technique imaging cells from the bone surface to inside the 
bone to a depth up to 450 mm with any region, angle or direction interested; (c) An 
example of an FITC image of the 6-mon-old rat tibia cortical bone revealing osteocyte 
(Ocy), osteoblast (Ob) lining cells, and osteoclast (OC); and (d) An example of a FITC-
osteon image of the 30-year-old femur cortical bone showing the Ocy-dendritic system 
surrounding the Haversian canal. (Published by Ren. Etc. on Connective Tissue Research 
2014 Aug;55) 
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Figure 1-2. Quantitation of osteocyte changes in the 8-wk-old Dmp1-null (KO) 
compared to the age-matched control (HET) mice using the FITC-Imaris technique. (a) 
Confocal FITC image shows spindle-shaped osteocytes with numerous dendrites in a well-
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 organized arrangement along the longitudinal axis in the HET (left) compared to the KO 
osteocytes, which are buried in poorly mineralized matrices (right) with much enlarged 
cell bodies that are less organized in structure and distribution, plus a few dendrites; (b) 
FITC confocal image reconstructed with the Imaris software revealed dense dendrites 
shown in artificial silver color (left, HET) compared to the KO tibia, in which there were 
20 osteocytes with dendrites selected and reconstructed, and the rest of them were not (red 
arrows, right); (c) The original FITC confocal images were removed, with the Imaris-
reconstructed images displayed only; and (d) The statistical analysis using Imaris software 
unveils a significant difference in total dendrite length, number, osteocyte surface area and 
total cell volume between the KO (n ¼ 20) and the HET control bone (n ¼ 25). (Published 
by Ren. Etc. on Connective Tissue Research 2014 Aug;55) 
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Figure 2-1  Ectopic ossification and severe defects of osteocytes and PDL in a patient 
with severe periodontitis. (a) The H&E stained images showed a poor PDL structure and 
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 ectopic ossification (left)compared to a control subject (right); (b-d) A very low level 
expression of DMP1 (b), MEPE (c), and periostin (d) compared to the alveolar bone or 
the control subject (right); and (e-g) FITC confocal images revealed a loss of PDL cells 
(e), and abnormalities of osteocytes (f-g, the cell body in expanded round shape and 
distributed in cluster with few dendrites) (g, full of fibers with few cells and vessels) in 
the same patient (left) d dentin 
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Figure 2-2  PDL is the major resource of progenitors in alveolar bone formation (1-
mon-old mandible). (a) The double labeling confocal images showed the widest distance 
between green (calcein) and red (alizarin red) lines in PDL-alveolar bone surface than 
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 periosteum and endosteum with a statistical difference; (b) The enlarge fluorochrome 
image revealed a double labeling layers surrounding the osteocyte (Ocy) plus yellow 
color minerals (overlaps of green and red labels) on the PDL-alveolar bone (Ab) surface, 
indicating a contribution of OCYs in mineralization and trace amount of minerals in the 
PDL- alveolar bone surface; (c) FTIC confocal images displayed a few newly formed 
Ocys on the Ab-PDL surface, supporting the possibility of the bone cells originated from 
PDL; (d) The acid-etched SEM image unveiled a mineral sheet closely linked to the Ocy 
and its dendrites; and (e) The X-gal stained jaw bone, in which a one-time adenovirus 
local  infection  in periosteum and PDL was performed 5 days before sample harvests. 
The blue cells reflect their origins from either the periosteum or PDL progenitors. 
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Figure 2-3  Restoration of bone loss and Ocy morphological shapes from round to 
spindle. (a) Representative radiographs revealed a restoration of bone loss in PKO jaw 
bones by removing Sost gene(right; DKO, double knockout); (b) Backscattered SEM 
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 images confirmed the rescue of bone loss in DKO mice (right); (c) qualitative (upper 
panels) and quantitative (lower panels) mCT data supported the above observation 
(right); and (d-e) Both backscattered SEM images (d) and acid etched SEM images (e) 
documented a direct correlation between changes of Ocy shapes and surrounding 
matrices in PKO (defects, middle) and DKO (rescue, middle) compared to the age-
matched control (left). ⃰ ⃰, p<0.01; *,p<0.05; n=5. 
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Figure 2-4  Rescue of Ocy morphological shapes from round to spindle. 
(a)Representative radiographs revealed a restoration of bone loss in PKO jaw bones by 
removing Sost gene (right; DKO, double knockout); (b) Backscattered SEM images 
confirmed the rescue of bone loss in DKO mice (right); (c) qualitative (upper panels) and 
quantitative (lower panels) µCT data supported the above observation (right); and (d-e) 
68 
 
 Both backscattered SEM images (d) and acid etched SEM images (e) documented a direct 
correlation between changes of Ocy shapes and surrounding matrices in PKO(defects, 
middle) and DKO (rescue, middle) compared to the age-matched control (left). ⃰ ⃰, p<0.01; 
*,p<0.05; n=5. 
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Figure 2-5  Restoration of bone loss, changes of the cementum-enamel junction(CEJ) 
area, and Ocy morphology in the 5-monthold periostin KO (PKO) after Scl-ab treatment 
for 8 weeks. (a). Representative radiograph images displayed a severe bone loss in the 
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 non-treat jaw bone (red arrow) and recovery of bone loss in the treated group (green arrow); 
(b). The µCT images confirmed the radiograph observation (left), and quantitative µCT 
data showed that this changes is statically significant; (c). Representative µCT images 
displayed an increase of CEJ area (pink) in the PKO mice, which was restored in the 
antibody treatment group (green arrow); and quantitative analyses showed that the CEJ 
changes in PKO mice are significant compared to either the age-matched control or 
treatment group. Note that 5 animals per group were selected for µCT scan. The images 
were rotated in a way crown pulp and root pulp are connected and perpendicular to the 
horizontal plane for estimation of CEJ area (red color) through over 100 “cutting” slides 
across the mandible (**, p<0.01; n=5). (d). Representative backscattered SEM image 
revealed an expanded canalicular and lacunar system in non-treat group, which is fully 
reversed in the treated group. 
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Figure 2-6  Restoration of molecular markers and collagen in double knockout (DKO) 
mice. (a) TRAP stains revealed a reduction of osteoclast number in DKO jaw bones; (b-
72 
 
 e) restorations of molecular markers in DKO mice by immunohistochemistry, including 
OSX (b),DMP1 (c), biglycan (d), and decorin (e); and (f) Dr. Ho’s data showed thinner 
bundling of fibers in PKO PDL, and restoration of PDL in DKO.  
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Figure 2-S1 Fig. S1.  Chronic inflammation and ectopic ossification in the patients with 
severe periodontitis. (a).In the case 1 (upper panel), the enlarged H&E image showed a 
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 mixture of many plasma cells(red arrow head) and few lymphocytes (arrows) with marrow 
fibrosis (black arrow head) from the infected alveolar bone adjacent to PDL(the low 
magnification of the extracted tooth and its surrounding tissues). The TRAP (Tartrate-
resistant acid phosphatase) assay revealed two active osteoclasts on the bone surfaces. In 
case 2(below), the bone marrow in the extracted alveolar bone, which was adjacent to the 
canine tooth, is filled with the mixture of huge amount of plasma cells (red arrow head) 
and few lymphocytes (arrows) plus Russell bodies (black arrows, plasma cells undergoing 
excessive synthesis of immunoglobulin and characteristic of the distended endoplasmic 
reticulum) with no sign of red blood cells. (b) The radiograph image of the canine 
extracted; and (b1-3) with b1, b2 and b3 areas for H&E stains, in which the PDL structure 
was substantially destroyed with few cells observed. There were numerous calcified 
tissues that are darker in color compared to the existing alveolar bone. d, dentin. 
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Figure 2-S2 Fig. S2  Deletion of periostin (PKO) lead to local changes of osteocytes 
(Ocys) and a sharp increase in SOST in the PKO jaw bone but not in long bone.(a) 
Representative radiographs revealed bone loss in PKO alveolar bone (right); (b) Acid 
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 etched SEM images displayed a sharp change of Ocys in jaw bone from spindle to round 
in PKO mice; (c) Acid etched SEM images displayed no apparent change of Ocys in PKO 
long bone; and (d-e) The immunohistochemistry stain images displayed a dramatic 
increase in SOST in the mandibular bone (d, rights) but a very mild change in the long 
bone(right). The above data support a link between the bone loss and the local changes of 
Ocy morphologies and an increase in SOST in the PKO jaw bone. 
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Figure 2-S3 Deletion of Sost KO leads to changes of Ocy morphologies.(a) 
Representative radiographs revealed an increase in Sost KO alveolar bone (right); (b) Acid 
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 etched SEM images displayed an osteon (the basic bone unit in mammalian but not in 
rodents) with a better Ocy organization in Sost KO mice (right); and (c) Backscattered 
SEM images revealed more defined Ocy structures in the Sost KO jawbone. 
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Figure 2-S4  Prevention of bone loss in PKO mice using Scl-ab for 8 weeks. (a). 
Representative radiograph images displayed bone loss at the age of 3-month (red arrow), 
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 which was fully prevented by using Scl-Ab for 8 weeks (green arrow); (b). Representative 
uCT images confirmed the radiograph observation; and (c).quantitative data showed that 
this changes is statically significant. *, p<0.05; **, p<0.01; and n=4-5. 
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Figure 2-S5  Restorations of osteoblast, osteoclast, and periodontal ligament (PDL) 
markers after treatment of periostin knockout mice (PKO) with Scl-ab for 8 weeks in 
the 12-wk-old group. (a). Representative OSX immunohistochemistry stains in WT (left), 
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 PKO (middle) PKO treated with Scl-ab (right); (b) TRAP stain images in these three 
groups; (c) Biglycan stain images in these three groups; (d) Sirius stain images by regular 
microscopy (upper) and polarized microscopy (lower) in these three groups; and(e) FITC 
stain images in these three groups. The data showed improvement of all these markers and 
PDL fibers in the PKO treated group.  
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Figure 2-S6  A close link between PDL and alveolar bone through Sharpe’s fibers. (a) 
A representative Azan stain image revealed Sharpe’s fibers in blue in the 10-month-old 
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 dog alveolar bone (AB); (b).Immunohistochemistry images displayed a high level of 
periostin in the dog PDL and Sharpe’s fiber (left), and osterix (Osx) in PDL progenitor 
and osteoblast cells (right); and (c). Immunohistochemistry images presented a high level 
of periostin in the mouse PDL and Sharpe’s fiber (left), and sclerostin(SOST) in osteocytes 
(right). 
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Figure 3-1  Murine bone mineralization is a prolonged process directly linked to Ocy 
maturation. a. SEM images of murine bone calvariae (0-10 days) revealed absent or 
multiple etched holes, indicative of poor mineralization and inadequate Ocy maturation 
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 and reflected by plump irregularly shaped cells and few flat dendrites per cell.   In contrast, 
murine bone calvariae (3 wk -5 mon) revealed resistance to acid etching and few holes in 
the matrix, due to enhanced matrix mineralization, which is evidence of progressive Ocy 
maturation, including a more complex dendritic network and eventual reduction in the cell 
volume and the transformation into a spindle shape, which is characteristic of a mature 
cell. b. SEM image of acid-etched cortical long bone from a 2 mon old mouse showed 
poor mineralization in the osteoid layer (evidenced by abundant holes in the matrix) and 
Ocy immaturity (plump Ocys with few flat dendrites), which progressed in the mature 
matrix to well-established mineralization (with resistance to acid etching from abundant 
calcium) and Ocy maturity (spindle-shaped cells with reduced volume). c. Confocal 
images of fluorochrome labeling counter-stained with DAPI displayed green, orange or 
green and red, and red-stained osteocytes and canaliculi; d. Double labeled images 
revealed an orange-labeled osteoid region in the more active trabecular bone, whose 
mineral deposition mainly originated from inner Ocys; and e. Polarized light image 
showing immature collagen in the entire 3-week-old cortical bone area, whereas the 
collagen was largely undetectable in the mature tibia region. 
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Figure 3-2 Abundant connections between osteocytes and blood vessels.  a. A 
representative acid-etched SEM image displayed numerous Ocy dendritic connections to 
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 both arteries and veins in cortical bone; b.  A representative acid-etched SEM image also 
revealed Ocy dendritic connections to a capillary vessel (CV) in cortical bone; c. A FITC 
confocal image of trabecular bone likewise displayed identical Ocy dendritic connections 
to a CV; and d. A TEM image of an Ocy adjacent to the endothelial cells in the wall of a 
CV documenting dye stain (black) trapped in the endothelial cells and in the Ocy 
cytoplasm and dendrites <2 minutes after dye injection into the rabbit abdominal aorta. 
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Figure 3-3 Impaired transition of osteoblasts into osteocytes is responsible for 
osteomalacia in Dmp1-null (KO) mice. a. Goldner stained images of cortical tibial bone 
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 from KO mice showed unique morphology, compared to heterozygous Dmp1 control 
mice, including  cells (arrows) embedded in abundant osteoid and; b. Backscattered SEM 
images revealed that the embedded cells in the KO mice were cuboidal and similar in 
appearance to osteoblasts; c. X-gal stained images of a tibia from heterozygous Dmp1 
control mice (with a lacZ knockin) showed the lacZ signal only in Ocys, while comparable 
Dmp1 KO mice exhibited lacZ positive cells in both Ocys and Ob-like cells, consistent 
with impaired transition of the osteoblasts into osteocytes; d.  BrdU-stained images 
revealed that the Ob-like cells in the osteoid of KO mice had high cell proliferation 
(arrows), whereas no proliferation was detected in specimens from the heterozygous mice; 
e. Polarized light images of cortical bone showed abundant but poorly organized collagen 
in the KO mice; f-j) In situ hybridization revealed dramatic increases in Ob markers, 
Runx2 (f), Osx (g), Cox2 (h), OC (i), and Tcf1 (j). 
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Figure 3-4 Sharp increases in Wnt-β-catenin signaling led to development of 
osteomalacia. a-b. Elevated β-catenin levels in Dmp1 KO mice were documented by 
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 immunostaining (a), and X-gal stain (b); c-h. Elevated β-catenin levels in offspring of 
Dmp1-Cre X Ctnnb1ex3flox  mice resulted in osteomalacia indistinguishable from that in 
Dmp1 KO mice, as evidenced by: Goldner stained sections of bone, which exhibited 
abundant red-staining osteoid (c), polarized light images that showed increased 
disorganized collagen (d), BrdU staining that documented increased proliferation of the 
Ob-like cells in the osteoid (e), and immunostains of Ob and early osteocyte markers, such 
as osterix (f), osteopontin (g), and E-11(j).    
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Figure 3-S1  Osteocytes (Ocys) form mineralized bone. a. The prevailing theory in bone 
biology is that osteoblasts (Obs) form mineralized bone.  b. A new model of bone 
formation, suggested by our novel finding, indicates that the role of the Obs is to 
differentiate into Ocys, which play a primary role in mineralized bone, as reflected by: i) 
Nascent Ocys (dark grey) produce and secrete collagen into the bone matrix and deposit 
small amounts of mineral (Ca-Pi) in the matrix; ii) Working together, the well-formed 
Ocys (light grey) and the mature Ocys (white) deposit Ca-Pi in the bone matrix, “pump” 
Ca-Pi through dendrites to the bone surface (two green lines with numerous “thorns”, 
bearing mineral secreted by the Ocys located in the calcified bone matrix), and deposit 
mineral in the matrix space created by the volume reduction of the Ocy cell body;   iii) Ca, 
Pi and nutrients are rapidly transported from surrounding blood vessels to Ocys; iv) DMP1 
controls the transition of Obs to Ocys and Ocys maturation; and v) the mature Ocys 
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 produce SOST (sclerostin), a potent inhibitor of Wnt-β-catenin, which modulates Ocy-
maturation and consequently mineralization (See Figure 3-1c).  c. In the Dmp1-null (KO) 
mouse (a model of osteomalacia) immature bone cells release large amounts of β-catenin, 
which accelerates Ob proliferation, while inhibiting cell differentiation, resulting in arrest 
at the Ob stage (although preserving high activity; blue stain) or the immature Ocy stage 
(grey stain) and failure to pump adequate Ca-Pi to surrounding bone matrix and bone 
surface (red stain-osteoid; green stain-calcified bone). 
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Figure 3-S2  Mineralization is directly linked to various phases of Ocy maturation. a. 
TEM and Goldner stained (insert) images, displaying an osteoblast (Ob) lining cell layer 
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 and an osteoid layer, in which the osteoid Ocys, like the Ob lining cells, are rich with 
rough endoplasmic reticulum and Golgi complexes, indicating that the Ocys may produce 
and secrete collagen. b. A backscattered SEM image, exhibiting a distinct mineral 
distribution pattern, wherein no mineral deposits are present in the surrounding matrix of 
the Ob lining cells (light grey color), small amounts of mineral are present in the osteoid 
layer (dark grey), a poorly formed mineral layer with a poorly organized sphere-like 
mineral structure is found in the early mineral layer (white color), and confluent mineral 
deposits are present in the mature matrix, in which the Ocys are well defined; Energy 
dispersive X-ray spectroscopy analyses of 10 random spots in each layer quantitatively 
confirmed these observations; and c. The acid-etched SEM image revealed: i) large holes 
(indicative of relatively complete removal of calcium) in the osteoid layer, as well as 
numerous newly formed Ocy dendrites that appear flat and clumped, ii) moderate removal 
of calcium in the poorly organized early mineral layer, uncovering a relatively well 
defined system of Ocy-dendrites that pierce deeply into the bone; and iii) limited removal 
of calcium in the highly calcified mature matrix, with exposure of only surface Ocy-
dendrites.    
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Figure 3-S3  Mineralization quality is closely associated with the osteocyte shape and 
its dendrite numbers   a, The acid-etched SEM images showed porotic bone in the mouse 
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 trabecular bone (upper) compared to the cortical bone (lower); b, a FITC confocal image, 
a “mirror” of a, displayed spindle-Ocys with numerous dendrites in the cortical bone 
region, whereas in the trabecular bone, there are few dendrites, and the Ocys are irregularly 
shaped in a non-organized pattern (left); c, the human FITC confocal images revealed a 
similar pattern in the trabecular (left) and cortical bone (right); d, Goldner images showed 
bone loss in a 99-year-old female femur (right) compared to the control (37-year-old male, 
left), although no apparent other bone changes observed by this technique; and e, the 
enlarged FITC images from the trabecular bone in white boxes revealed a dramatic 
changes of osteocytes from spindle in the control (left image) to round with much enlarged 
cytoplasm (i.e., more mineral matrices lost, right image), which are responsible for poor 
bone quality in the osteoporosis patient. Of note is that both samples were obtained from 
cadaver bodies.  
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Figure 3-S4  Bones grow from the inside to the outside. Calcein was injected into 7-wk-
old WT mice followed by Alizarin Red 5 days later, and the mice were sacrificed at age 
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 of 8 wk. A series of 10-mm sections of a plastic-embedded long bone was counter stained 
with DAPI stain followed by confocal imaging. a. The surface sagittal section displayed 
double-labelled mineralized fronts plus numerous red stained osteocytes and their 
dendrites (arrows), suggesting that osteocytes continuously deposit minerals in bone 
matrices and bone surfaces of the endosteum and periosteum (inserts) with no mineral 
contributions from the osteoblast (Ob) on bone surfaces; b. The deep bone section 
displayed two color-stained osteocytes: green (indicating mineral deposition at an early 
phase) and orange (suggesting these cells deposit minerals at both phases). 
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Figure 3-S5  There is a small amount of Mineral in the osteoid layer is mainly formed 
from inner Ocys. Calcein was injected into  7-wk-old WT mice followed by Alizarin Red 
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 5 days later, and the mice were sacrificed at age of 8 wk. a. Overlapping both red and 
green lights revealed an orange line, reflecting contributions of inner Ocys for a small 
amount mineral in the osteoid layer. b. The green light view only, showing one bolt line 
and one thin surface line; and c. The red light view only, showing one bolt line and one 
thin surface line. 
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Figure 3-S6  Direct communication between capillary vessels and osteocytes (Ocy). An 
adult rabbit was under intravenous anesthesia with pentobarbital (30 mg/kg), followed by 
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 catheter placement into the abdominal aorta. Ten ml of PBS was used to flush out blood, 
and then a 5% sodium metaperiodate solution (dye with molecular weight of 213.89) was 
injected into the bloodstream, followed by immediate fixation with less than a 2-minute 
delay. a. The TEM image showed a capillary vessel surrounded by numerous Ocy-
dendrites Most of the dye filled the cytoplasm of the Ocy-dendrites with dye (black color) 
filled in the cytoplasm of the cell body and dendrites but not in matrices. b. The enlarge 
TEM image displayed dye in the cytoplasm of endothelial (End) and Ocy-dendrites 
(arrows). 
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Figure 3-S7  Loss of Dmp1, a gene highly expressed in osteocytes (Ocys), leads to an 
osteomalacic phenotype. a. a representative immunostain image displays a high level of 
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 DMP1 in the extracellular matrix surrounding the Ocy and dendrites but not in the matrix 
surrounding osteoblast (Ob); b. Photographs of 3-month old tibias (mid) showed dramatic 
changes in Dmp1 knockout (KO) bone in size and shape; the Von Kossa stain images 
revealed a sharp increase in osteoid (red, right image) content (10-fold higher than 
heterozygous control, HET, n=4, p<0.001). c. Representative acid-etched SEM images 
display a large amount of osteoid in the KO long bone (a cross sectional view, arrows) 
compared to that in Dmp1 HET control bone (left). The Dmp1 KO image (insert) shows a 
great morphological change in the KO’s Ocy bodies with few dendrites and loss of 
surrounding matrices, indicating poor mineral content directly linked to morphological 
changes of the KO Ocys; d.  FITC confocal images further confirmed a large amount of 
osteoid and malformed Ocy with few dendrites in the KO mouse bone (right) compared 
to that in the HET (left) mice.  
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Figure 3-S8  A sharp reduction of sclerostin expression in a 3-wk old Dmp1-null (KO) 
tibia. The representative immunostain image displays a high level of sclerostin in the 
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 mature osteocytes and dendrites (left) compared to the age matched KO tibia, where 
sclerostin was largely undetectable (right images). (Unpublished Data from Shuxian Lin) 
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Figure 4-1  Wnt/β-catenin signaling was up-regulated in the osteocyte of Dmp1-null 
mice. (a) The mRNA expression level of β-catenin showed a more than 15-fold up-
regulation in Dmp1-null mice compared to the controls. Data are presented as mean ± 
SEM; n=6 in each group; *P<0.05; **P<0.01. (b) Immunohistochemistry staining of β-
catenin revealed an increased expression of β-catenin in the osteocytes. The arrow in the 
magnified box indicated a nuclear localization of β-catenin. (c) X-gal positive osteocytes 
were found in the Dmp1 conditional knockout (3.6 kb Col1 Cre; Dmp1fx/fx; Top-gal+) 
mouse long bones (arrows), compared to few positive osteocytes in the control group 
(Dmp1fx/fx; Top-gal+). Note the β-galactosidase gene was driven by a TCF-β-catenin 
responsive promoter in the Top-gal mouse, so canonical Wnt activity was detected by X-
gal staining. (d) In situ hybridization staining demonstrated the Tcf expression that was 
up-regulated in the osteocytes of Dmp1-null mice (arrows). (Unpublished data from 
Shuxian Lin) 
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Figure 4-2  Constitutive stabilization of β-catenin in osteocytes recaptured osteomalacia 
phenotype and displayed deformed osteocytes. (a-c) Elevated β-catenin levels in offspring 
of CA-β (Dmp1-Cre; β-catex3loxP/+) mice resulted in osteomalacia indistinguishable from 
that in Dmp1-KO mice, as evidenced by: polarized light images, in which green means 
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 thinner collagen fibers such as reticular fibers, whereas red or orange indicates larger 
collagen fibers such as collagen type I,  showing increased disorganized collagen (a); 
Biglycan staining that appeared more positively stained area (b); Goldner-stained sections 
of bone, which exhibited abundant red-staining osteoid (c). (d-g) Increased β-catenin 
levels in osteocytes caused maturation defects, as supported by immunostains of osteoblast 
and early osteocyte markers, such as OSX (d), OPN (e), and E11 (g) showed apparently 
elevated expressions; BrdU staining that documented increased proliferation of the 
immature osteocytes in the osteoid (g). (Unpublished data from Shuxian Lin) 
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Figure 4-3 Normalizing the Wnt/β-catenin activity greatly improves the bone 
morphology. (a-b) Representative radiographs of 3-wk (a) and 8-wk (b) groups. Note the 
long bone shape was better formed in the DKK1; KO mice, compared to the KO groups. 
Also, in the KO mice, the bone accumulation appeared in the metaphysis (arrowhead) and 
the epiphyseal structures were disorganized and malformed (arrows), but were notably 
improved by Dkk1-Tg. (c) μ-CT images of different tibia cross sections indicated 
malformed epiphysis structure, obvious bone accumulation in the metaphysis (arrow), and 
porous cortical bone (arrowhead) in the KO mice, which was partially rescued by Dkk1-
Tg. (d-f) Statistical analysis of epiphysis area (d), tibia length (e), and cortical porosity (f) 
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 indicated significances between KO and DKK1; KO groups. Data are presented as mean 
± SEM; n=5 in each group; *P<0.05; **P<0.01. (Unpublished data from Shuxian Lin) 
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Fig 4-4.  SOST function in a autocrine manner and target on its own cell to regulate 
gene expression. (a). Through the maturation from osteo-progenitor cells to osteocytes, 
SOST expression increases as the cell mature and target the cell itself. (b), old dogma 
showed SOST works as a paracrine and secreted by mature osteocyte to target on bone 
lining osteoblasts and progenitor cells in response to mechanical forces. 
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Figure 4-5  SOST is expressed in bone marrow and osteoblast cells, as well as in 
osteocytes. a) The X-gal-stained image of Sost-lacZ knock-in HET bone revealed SOST-
lacZ expressions in bone marrow (Bm), osteoblast (Ob) and osteocyte cells at the ages of 
newborn (NB) and day 7; b) The X-gal-stained image of Sost-lacZ knock-in HET bone 
revealed SOST-lacZ expressions in the periosteum and cortical bone at the ages of days 
14 and 28; c) In situ hybridization showed Sost mRNA (red) in the bone marrow and 
osteoblast lining cells (left image), and quantitative RT-PCR data showed Sost expression 
in cortical bone (with both periosteum and endosteum removed) and bone marrow cells; 
and d) Western blot from the cultured primary mesenchymal cells obtained from mouse 
bone marrows (lines 1-2) and rat bone marrows (line 5) showed SOST expressions 
compared to the tooth pulp primary cells (lines 3-4 are from mouse and line 6 is from rat). 
Altogether, the above data highlight a new source of SOST in bone marrow and osteoblast 
cells, which are not released from osteocytes as commonly speculated. 
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Figure 4-6  Gene expression changes of MC3T3 (Ob) cell line and MLOY4 (Ocy) cell 
line 36 hours after Scl-Ab administration (500ng/ml). (a) Anti-SOST antibody on 
osteoblast cell line (MC3T3) revealed no significant gene expression level changes 
including SOST. (b). Anti-SOST antibody down-regulated SOST expression by close to 
70% in MLOY4 Osteocyte cell line, and significantly decreased RankL and increased 
Dmp1 expression. 
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